Utestående aktier | 44,932,721 shares |
Insideraktier | 13 265 602 shares |
Insynsägande | 29,52 % |
Totalt antal insynspersoner | 60 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
-0.018 %( )
10083 out of 11221Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Pacira BioSciences, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|---|---|---|
Marcelo Bigal Director - [D] | 11 393 | 11 393 | |
Scott Braunstein SVP, Strategy & Corp. Dev. - [O] | 20 982 | 20 982 | |
Laura Brege Director - [D] | 23 715 | 23 715 | |
Christopher Christie Director - [D] | 16 654 | 16 654 | |
Abraham Ceesay Director - [D] | 9 039 | 9 039 | |
Shawn Cross Chief Financial Officer - [O] | 75 000 | 75 000 | |
Luke Evnin Director - [D] | 0 | 0 | |
Ellis Ronald J. Jr. Chief Strategy Officer - [O] | 30 909 | 30 909 | |
Todd Foley - | 2 790 479 | 2 790 479 | |
Mark Froimson Director - [D] | 20 636 | 20 636 | |
Ansbert Gadicke - | 2 790 479 | 2 790 479 | |
Daryl Gaugler Chief Operating Officer - [O] | 115 443 | 115 443 | |
Yvonne Greenstreet Director - [D] | 13 247 | 13 247 | |
Paul J Hastings Director - [D] | 12 724 | 12 724 | |
HBM Healthcare Investments (Cayman) Ltd.
10% Owner -
|
2 233 993 | 2 233 993 | |
Samuel D Isaly
10% Owner -
|
2 446 000 | 2 446 000 | |
James B Jones SVP & Chief Medical Officer - [O] | 16 823 | 16 823 | |
Vaughn M Kailian - | 2 790 479 | 2 790 479 | |
Kronenfeld Mark A. Director - [D] | 34 901 | 34 901 | |
Charles Anthony Laranjeira Chief Technical Officer - [O] | 41 752 | 41 752 |
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|---|---|---|
John P Phd Longenecker Director - [D] | 18 823 | 18 823 | |
Lee Frank D. Chief Executive Officer, Director - [D] [O] | 448 409 | 448 409 | |
Fred A Middleton Director - [D] | 0 | 0 | |
Anthony Molloy Chief Lgl & Compliance Officer - [O] | 12 877 | 12 877 | |
MPM Asset Management Investors BV4 LLC - | 2 790 479 | 2 790 479 | |
MPM BioVentures IV GP LLC - | 2 790 479 | 2 790 479 | |
MPM BioVentures IV GmbH & Co. Beteiligungs KG - | 2 790 479 | 2 790 479 | |
MPM BioVentures IV LLC - | 2 790 479 | 2 790 479 | |
MPM BioVentures IV QP LP - | 2 790 479 | 2 790 479 | |
Manning Donald C. Chief Medical Officer - [O] | 29 520 | 29 520 | |
Taunia Markvicka SVP, Chief Commercial Officer - [O] | 8 579 | 8 579 | |
Dennis McLoughlin Chief Customer Officer - [O] | 38 115 | 38 115 | |
Orbimed Advisors Llc
10% Owner -
|
2 446 000 | 2 446 000 | |
OrbiMed Capital GP III LLC
10% Owner -
|
2 446 000 | 2 446 000 | |
Gary W Pace Director - [D] | 22 127 | 22 127 | |
Gary Patou Chief Medical Officer - [O] | 0 | 0 | |
John Pratt General Manager, San Diego - [O] | 0 | 0 | |
Max Reinhardt President, Rest of World - [O] | 29 225 | 29 225 | |
Reinhart Charles A. III Chief Financial Officer - [O] | 51 867 | 51 867 | |
Lauren Bullaro Riker Senior Vice President, Finance - [O] | 59 564 | 59 564 |
Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
---|---|---|---|
Sanderling Venture Partners Iv Co Investment Fund Lp
10% Owner -
|
1 483 596 | 0 | |
Jonathan Slonin Chief Medical Officer - [O] | 182 327 | 182 327 | |
David M Stack CEO and Chairman, Director - [D] [O] | 302 665 | 302 665 | |
Sanderling VI Beteiligungs GmbH & Co KG
10% Owner -
|
42 833 | 559 453 | |
Sanderling VI Limited Partnership
10% Owner -
|
42 833 | 559 453 | |
Sanderling Venture Partners VI Co Investment Fund LP
10% Owner -
|
42 833 | 559 453 | |
Sanderling Venture Partners VI LP
10% Owner -
|
559 453 | 559 453 | |
Ventures Management VI Sanderling
10% Owner -
|
1 483 596 | 0 | |
James S Scibetta President - [O] | 25 118 | 25 118 | |
James Paul Scopa - | 2 790 479 | 2 790 479 | |
Richard Scranton Chief Scientific Officer - [O] | 16 061 | 16 061 | |
Brendan Teehan Chief Commercial Officer - [O] | 54 000 | 54 000 | |
Vort John Vander - | 2 790 479 | 2 790 479 | |
Dennis L Winger Director - [D] | 7 490 | 7 490 | |
Roy Winston Chief Medical Officer - [O] | 52 440 | 52 440 | |
Weiland Robert J. Chief Commercial Officer - [O] | 5 088 | 5 088 | |
Andreas Wicki Director - [D] | 451 324 | 451 324 | |
Kristen Marie Williams Chief Administrative Officer - [O] | 161 574 | 161 574 | |
Yang Michael J. Director - [D] | 13 393 | 13 393 | |
Alethia Young Director - [D] | 11 393 | 11 393 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PCRX / Pacira BioSciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PCRX / Pacira BioSciences, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-08 | 2025-09-04 | 4 | Ceesay Abraham | PCRX | Common Stock | D | 27,1900 | −2 354 | −64 | 9 039 | ||||
2025-08-11 | 2025-08-07 | 4 | BIGAL MARCELO | PCRX | Common Stock | D | 23,6700 | −4 912 | −116 | 11 393 | ||||
2025-08-04 | 2025-08-01 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 22,0700 | −315 | −7 | 182 327 | ||||
2025-06-13 | 2025-06-11 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 9 999 | 34 901 | ||||||
2025-06-13 | 2025-06-11 | 4 | BIGAL MARCELO | PCRX | Common Stock | D | 6 163 | 16 305 | ||||||
2025-06-13 | 2025-06-11 | 4 | Froimson Mark | PCRX | Common Stock | D | 6 163 | 20 636 | ||||||
2025-06-13 | 2025-06-11 | 4 | Ceesay Abraham | PCRX | Common Stock | D | 6 163 | 11 393 | ||||||
2025-06-13 | 2025-06-11 | 4 | Brege Laura | PCRX | Common Stock | D | 6 163 | 23 715 | ||||||
2025-06-13 | 2025-06-11 | 4 | Young Alethia | PCRX | Common Stock | D | 6 163 | 11 393 | ||||||
2025-06-13 | 2025-06-11 | 4 | CHRISTIE CHRISTOPHER | PCRX | Common Stock | D | 6 163 | 16 654 | ||||||
2025-06-13 | 2025-06-11 | 4 | YANG MICHAEL J. | PCRX | Common Stock | D | 6 163 | 13 393 | ||||||
2025-06-05 | 2025-06-04 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 26,2100 | −5 578 | −146 | 59 564 | ||||
2025-06-05 | 2025-06-03 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 26,4000 | −3 374 | −89 | 65 142 | ||||
2025-06-05 | 2025-06-03 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 26,4000 | −5 084 | −134 | 181 960 | ||||
2025-06-05 | 2025-06-04 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 26,2400 | −14 376 | −377 | 161 574 | ||||
2025-06-05 | 2025-06-03 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 26,4000 | −6 162 | −163 | 175 950 | ||||
2025-02-04 | 2025-02-01 | 4 | Teehan Brendan | PCRX | Common Stock | D | 54 000 | 54 000 | ||||||
2025-02-04 | 2025-02-01 | 4 | Lee Frank D. | PCRX | Common Stock | D | 350 000 | 448 409 | ||||||
2025-02-04 | 2025-02-01 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 79 200 | 182 112 | ||||||
2025-02-04 | 2025-02-01 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 93 600 | 187 044 | ||||||
2025-02-04 | 2025-02-01 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 30 600 | 68 516 | ||||||
2025-01-06 | 2024-12-31 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 16,0140 | 244 | 4 | 115 443 | ||||
2025-01-06 | 2025-01-02 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 18,3300 | −159 | −3 | 37 916 | ||||
2025-01-06 | 2025-01-06 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 18,4000 | −879 | −16 | 93 444 | ||||
2025-01-06 | 2025-01-02 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 18,3300 | −371 | −7 | 94 323 | ||||
2025-01-06 | 2025-01-02 | 4 | Lee Frank D. | PCRX | Common Stock | D | 18,3300 | −9 375 | −172 | 98 409 | ||||
2024-12-16 | 2024-12-13 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 19,7600 | −500 | −10 | 115 200 | ||||
2024-11-05 | 2024-11-01 | 4 | Cross Shawn | PCRX | Common Stock | D | 75 000 | 75 000 | ||||||
2024-09-13 | 2024-09-13 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 12,8600 | −500 | −6 | 115 700 | ||||
2024-08-19 | 2024-08-16 | 4 | BIGAL MARCELO | PCRX | Common Stock | D | 13,2500 | 1 512 | 20 | 10 142 | ||||
2024-08-19 | 2024-08-16 | 4 | Brege Laura | PCRX | Common Stock | D | 12,8100 | 1 000 | 13 | 17 552 | ||||
2024-08-14 | 2024-08-14 | 4 | YANG MICHAEL J. | PCRX | Common Stock | D | 12,9000 | 2 000 | 26 | 7 230 | ||||
2024-08-13 | 2024-08-12 | 4 | Lee Frank D. | PCRX | Common Stock | D | 12,1000 | 8 264 | 100 | 107 784 | ||||
2024-08-13 | 2024-08-12 | 4/A | BIGAL MARCELO | PCRX | Common Stock | D | 12,0100 | 3 400 | 41 | 8 630 | ||||
2024-08-12 | 2024-08-12 | 4 | BIGAL MARCELO | PCRX | Common Stock | D | 12,0100 | 3 400 | 41 | 8 630 | ||||
2024-08-12 | 2024-08-12 | 4 | Froimson Mark | PCRX | Common Stock | D | 11,5800 | 1 400 | 16 | 14 473 | ||||
2024-08-02 | 2024-08-02 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 20,0500 | −945 | −19 | 94 307 | ||||
2024-08-02 | 2024-08-01 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 20,7500 | −305 | −6 | 95 252 | ||||
2024-07-03 | 2024-06-28 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 24,3190 | 160 | 4 | 116 200 | ||||
2024-07-03 | 2024-07-02 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 28,2500 | −2 836 | −80 | 95 557 | ||||
2024-07-03 | 2024-07-01 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 28,4600 | −914 | −26 | 98 393 | ||||
2024-07-03 | 2024-06-28 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 24,3190 | 437 | 11 | 99 307 | ||||
2024-06-13 | 2024-06-12 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 54 300 | 98 869 | ||||||
2024-06-13 | 2024-06-11 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 28,5700 | −5 012 | −143 | 44 569 | ||||
2024-06-13 | 2024-06-12 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 28,7200 | −3 970 | −114 | 38 075 | ||||
2024-06-13 | 2024-06-12 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 21 360 | 42 045 | ||||||
2024-06-13 | 2024-06-12 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 12 220 | 51 867 | ||||||
2024-06-13 | 2024-06-12 | 4 | BIGAL MARCELO | PCRX | Common Stock | D | 5 230 | 5 230 | ||||||
2024-06-13 | 2024-06-12 | 4 | CHRISTIE CHRISTOPHER | PCRX | Common Stock | D | 5 230 | 10 491 | ||||||
2024-06-13 | 2024-06-13 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 28,3800 | −880 | −25 | 12 724 | ||||
2024-06-13 | 2024-06-12 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 5 230 | 13 604 | ||||||
2024-06-13 | 2024-06-12 | 4 | Froimson Mark | PCRX | Common Stock | D | 5 230 | 13 073 | ||||||
2024-06-13 | 2024-06-12 | 4 | Young Alethia | PCRX | Common Stock | D | 5 230 | 5 230 | ||||||
2024-06-13 | 2024-06-13 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 28,3800 | −1 000 | −28 | 116 040 | ||||
2024-06-13 | 2024-06-12 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 54 300 | 117 040 | ||||||
2024-06-13 | 2024-06-12 | 4 | Ceesay Abraham | PCRX | Common Stock | D | 5 230 | 5 230 | ||||||
2024-06-13 | 2024-06-12 | 4 | YANG MICHAEL J. | PCRX | Common Stock | D | 5 230 | 5 230 | ||||||
2024-06-13 | 2024-06-12 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 5 230 | 24 902 | ||||||
2024-06-13 | 2024-06-13 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 28,3800 | −7 452 | −211 | 102 912 | ||||
2024-06-13 | 2024-06-12 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 54 300 | 110 364 | ||||||
2024-06-13 | 2024-06-12 | 4 | Brege Laura | PCRX | Common Stock | D | 5 230 | 16 552 | ||||||
2024-06-05 | 2024-06-03 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 30,8900 | −2 979 | −92 | 39 647 | ||||
2024-06-05 | 2024-06-03 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 30,8900 | −3 011 | −93 | 56 064 | ||||
2024-06-05 | 2024-06-03 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 30,8900 | −1 843 | −57 | 20 685 | ||||
2024-06-05 | 2024-06-03 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 30,8900 | −1 615 | −50 | 49 581 | ||||
2024-06-05 | 2024-06-03 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 30,8900 | −2 754 | −85 | 62 740 | ||||
2024-03-08 | 2024-03-08 | 4 | PACE GARY W | PCRX | Common Stock | D | 30,6000 | −90 000 | −2 754 | 22 127 | ||||
2024-03-08 | 2024-03-07 | 4 | PACE GARY W | PCRX | Common Stock | D | 30,8100 | −28 257 | −871 | 112 127 | ||||
2024-03-08 | 2024-03-06 | 4 | PACE GARY W | PCRX | Common Stock | D | 29,6700 | −1 066 | −32 | 140 384 | ||||
2024-02-07 | 2024-02-05 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 33 700 | 65 494 | ||||||
2024-02-07 | 2024-02-05 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 33 700 | 59 075 | ||||||
2024-01-04 | 2024-01-02 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 32,0000 | −159 | −5 | 22 528 | ||||
2024-01-04 | 2024-01-02 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 5 000 | 51 196 | ||||||
2024-01-04 | 2024-01-02 | 4 | Lee Frank D. | PCRX | Common Stock | D | 99 520 | 99 520 | ||||||
2023-12-07 | 3 | SLONIN JONATHAN | PCRX | Common Stock | D | 45 885 | ||||||||
2023-08-04 | 2023-08-02 | 4 | WINSTON ROY | PCRX | Common Stock | D | 34,8750 | −509 | −18 | 52 440 | ||||
2023-07-07 | 2023-07-05 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 38,9100 | −643 | −25 | 22 687 | ||||
2023-06-16 | 2023-06-14 | 4 | WINSTON ROY | PCRX | Common Stock | D | 10 950 | 52 306 | ||||||
2023-06-16 | 2023-06-14 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 37,0300 | −6 467 | −239 | 25 375 | ||||
2023-06-16 | 2023-06-14 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 10 950 | 31 842 | ||||||
2023-06-16 | 2023-06-14 | 4 | STACK DAVID M | PCRX | Common Stock | D | 32 700 | 186 481 | ||||||
2023-06-16 | 2023-06-14 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 39,0100 | −7 | −0 | 22 687 | ||||
2023-06-16 | 2023-06-14 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 38,5200 | −5 773 | −222 | 22 694 | ||||
2023-06-16 | 2023-06-14 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 37,4700 | −586 | −22 | 28 467 | ||||
2023-06-16 | 2023-06-14 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10 000 | 29 053 | ||||||
2023-06-16 | 2023-06-14 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 9 000 | 42 626 | ||||||
2023-06-16 | 2023-06-14 | 4 | PACE GARY W | PCRX | Common Stock | D | 1 775 | 141 450 | ||||||
2023-06-16 | 2023-06-14 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 1 775 | 19 672 | ||||||
2023-06-16 | 2023-06-14 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 10 000 | 31 539 | ||||||
2023-06-16 | 2023-06-14 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 1 775 | 8 374 | ||||||
2023-06-16 | 2023-06-14 | 4 | Froimson Mark | PCRX | Common Stock | D | 1 775 | 7 843 | ||||||
2023-06-16 | 2023-06-14 | 4 | CHRISTIE CHRISTOPHER | PCRX | Common Stock | D | 1 775 | 5 261 | ||||||
2023-06-16 | 2023-06-14 | 4 | Brege Laura | PCRX | Common Stock | D | 1 775 | 11 322 | ||||||
2023-06-12 | 2023-06-08 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 37,0400 | −15 000 | −556 | 17 897 | ||||
2023-06-12 | 2023-06-08 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 29,9000 | 15 000 | 448 | 32 897 | ||||
2023-06-07 | 2023-06-07 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 37,8650 | −1 357 | −51 | 20 892 | ||||
2023-06-07 | 2023-06-06 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,9910 | −1 301 | −51 | 22 249 | ||||
2023-06-07 | 2023-06-07 | 4 | WINSTON ROY | PCRX | Common Stock | D | 37,8650 | −1 857 | −70 | 41 356 | ||||
2023-06-07 | 2023-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 38,9910 | −1 779 | −69 | 43 213 | ||||
2023-06-07 | 2023-06-07 | 4 | STACK DAVID M | PCRX | Common Stock | D | 37,8650 | −5 326 | −202 | 153 781 | ||||
2023-06-07 | 2023-06-06 | 4 | STACK DAVID M | PCRX | Common Stock | D | 38,9910 | −5 058 | −197 | 159 107 | ||||
2023-06-07 | 2023-06-07 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 37,8650 | −490 | −19 | 36 323 | ||||
2023-06-07 | 2023-06-06 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 38,9910 | −471 | −18 | 36 813 | ||||
2023-06-07 | 2023-06-07 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 37,8650 | −616 | −23 | 19 053 | ||||
2023-06-07 | 2023-06-06 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 38,9910 | −591 | −23 | 19 669 | ||||
2023-06-07 | 2023-06-07 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 37,8650 | −1 371 | −52 | 33 626 | ||||
2023-06-07 | 2023-06-06 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 38,9910 | −1 236 | −48 | 34 997 | ||||
2023-06-07 | 2023-06-07 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 37,8650 | −1 099 | −42 | 29 225 | ||||
2023-06-07 | 2023-06-06 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 38,9910 | −1 054 | −41 | 30 324 | ||||
2023-06-07 | 2023-06-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 38,5500 | −4 521 | −174 | 12 877 | ||||
2023-06-07 | 2023-06-05 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 38,2770 | −2 267 | −87 | 17 398 | ||||
2023-06-07 | 2023-06-07 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 37,8650 | −1 057 | −40 | 38 115 | ||||
2023-06-07 | 2023-06-06 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 38,9910 | −1 014 | −40 | 39 172 | ||||
2023-06-07 | 2023-06-05 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 38,3390 | −580 | −22 | 6 599 | ||||
2023-06-07 | 2023-06-07 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 37,8650 | −1 047 | −40 | 21 539 | ||||
2023-06-07 | 2023-06-06 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 38,9910 | −1 005 | −39 | 22 586 | ||||
2023-06-07 | 2023-06-05 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 38,7400 | −1 000 | −39 | 23 591 | ||||
2023-06-07 | 2023-06-07 | 4 | Ellis Ronald J. Jr. | PCRX | Common Stock | D | 37,8650 | −1 162 | −44 | 30 909 | ||||
2023-06-07 | 2023-06-06 | 4 | Ellis Ronald J. Jr. | PCRX | Common Stock | D | 38,9910 | −1 114 | −43 | 32 071 | ||||
2023-06-07 | 2023-06-05 | 4 | Brege Laura | PCRX | Common Stock | D | 38,7400 | −600 | −23 | 9 547 | ||||
2023-06-02 | 2023-05-31 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 39,0800 | −2 500 | −98 | 24 591 | ||||
2023-06-02 | 2023-05-31 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 34,0000 | 2 500 | 85 | 26 894 | ||||
2023-05-17 | 2023-05-15 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 41,8500 | −7 000 | −293 | 7 179 | ||||
2023-05-17 | 2023-05-15 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 29,9000 | 7 000 | 209 | 14 179 | ||||
2023-05-15 | 2023-05-11 | 4 | PACE GARY W | PCRX | Common Stock | D | 41,7800 | −5 015 | −210 | 139 675 | ||||
2023-05-15 | 2023-05-11 | 4 | PACE GARY W | PCRX | Common Stock | D | 29,9000 | 7 000 | 209 | 144 690 | ||||
2023-04-05 | 2023-04-03 | 4 | Brege Laura | PCRX | Common Stock | D | 40,7200 | −7 000 | −285 | 10 147 | ||||
2023-04-05 | 2023-04-03 | 4 | Brege Laura | PCRX | Common Stock | D | 29,9000 | 7 000 | 209 | 17 147 | ||||
2023-03-28 | 3 | Ellis Ronald J. Jr. | PCRX | Common Stock | D | 33 185 | ||||||||
2023-01-06 | 2023-01-05 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 38,3100 | −546 | −21 | 19 450 | ||||
2023-01-06 | 2023-01-04 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 39,0930 | −158 | −6 | 19 996 | ||||
2022-10-11 | 2022-10-07 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 58,0000 | −1 380 | −80 | 31 378 | ||||
2022-08-05 | 2022-08-03 | 4 | WINSTON ROY | PCRX | Common Stock | D | 55,7000 | −476 | −27 | 44 992 | ||||
2022-08-05 | 2022-08-03 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 55,7000 | −308 | −17 | 37 079 | ||||
2022-07-13 | 2022-07-11 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 56,9500 | −533 | −30 | 7 179 | ||||
2022-07-07 | 2022-07-05 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 57,1880 | −924 | −53 | 37 387 | ||||
2022-06-16 | 2022-06-14 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 38,3500 | 6 000 | 230 | 41 752 | ||||
2022-06-08 | 2022-06-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 21 500 | 163 751 | ||||||
2022-06-08 | 2022-06-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 61,9600 | −501 | −31 | 142 251 | ||||
2022-06-08 | 2022-06-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 61,3100 | −1 282 | −79 | 142 752 | ||||
2022-06-08 | 2022-06-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 60,3300 | −5 006 | −302 | 144 034 | ||||
2022-06-08 | 2022-06-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 59,1000 | −7 039 | −416 | 149 040 | ||||
2022-06-08 | 2022-06-06 | 4 | STACK DAVID M | PCRX | Common Stock | D | 61,3740 | −11 965 | −734 | 156 079 | ||||
2022-06-08 | 2022-06-08 | 4 | WINSTON ROY | PCRX | Common Stock | D | 9 900 | 45 060 | ||||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 63,6900 | −123 | −8 | 35 160 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 62,4800 | −1 891 | −118 | 35 283 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 61,5900 | −3 650 | −225 | 37 174 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 60,5500 | −3 533 | −214 | 40 824 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 63,4000 | −115 | −7 | 44 357 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 62,4300 | −1 300 | −81 | 44 472 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 61,5900 | −2 300 | −142 | 45 772 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 60,5500 | −2 535 | −153 | 48 072 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 34,3750 | 6 250 | 215 | 50 607 | ||||
2022-06-08 | 2022-06-06 | 4 | WINSTON ROY | PCRX | Common Stock | D | 61,3740 | −2 099 | −129 | 44 357 | ||||
2022-06-08 | 2022-06-08 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 9 900 | 23 550 | ||||||
2022-06-08 | 2022-06-07 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 59,5100 | −4 649 | −277 | 13 650 | ||||
2022-06-08 | 2022-06-06 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 61,3740 | −3 969 | −244 | 18 299 | ||||
2022-06-08 | 2022-06-08 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 9 900 | 38 097 | ||||||
2022-06-08 | 2022-06-06 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 61,3740 | −362 | −22 | 28 197 | ||||
2022-06-08 | 2022-06-08 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 5 850 | 19 852 | ||||||
2022-06-08 | 2022-06-06 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 61,3740 | −1 150 | −71 | 14 002 | ||||
2022-06-08 | 2022-06-08 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 7 950 | 36 233 | ||||||
2022-06-08 | 2022-06-06 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 61,3740 | −2 516 | −154 | 28 283 | ||||
2022-06-08 | 2022-06-08 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 9 900 | 35 752 | ||||||
2022-06-08 | 2022-06-08 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 61,9800 | −267 | −17 | 25 852 | ||||
2022-06-08 | 2022-06-08 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 60,9900 | −516 | −31 | 26 119 | ||||
2022-06-08 | 2022-06-08 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 60,2300 | −1 633 | −98 | 26 635 | ||||
2022-06-08 | 2022-06-08 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 59,0800 | −2 521 | −149 | 28 268 | ||||
2022-06-08 | 2022-06-06 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 61,3740 | −2 813 | −173 | 30 789 | ||||
2022-06-08 | 2022-06-08 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 7 950 | 32 250 | ||||||
2022-06-08 | 2022-06-07 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 62,0000 | −2 433 | −151 | 24 400 | ||||
2022-06-08 | 2022-06-06 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 61,3740 | −2 817 | −173 | 26 833 | ||||
2022-06-08 | 2022-06-08 | 4 | PACE GARY W | PCRX | Common Stock | D | 1 160 | 137 690 | ||||||
2022-06-08 | 2022-06-08 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 7 950 | 19 950 | ||||||
2022-06-08 | 2022-06-07 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 60,4000 | −1 830 | −111 | 12 000 | ||||
2022-06-08 | 2022-06-07 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 59,3800 | −740 | −44 | 13 830 | ||||
2022-06-08 | 2022-06-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 61,3740 | −2 980 | −183 | 14 570 | ||||
2022-06-08 | 2022-06-08 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 7 950 | 39 770 | ||||||
2022-06-08 | 2022-06-06 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 61,3740 | −2 140 | −131 | 31 820 | ||||
2022-06-08 | 2022-06-08 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 1 160 | 17 897 | ||||||
2022-06-08 | 2022-06-08 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 1 160 | 7 712 | ||||||
2022-06-08 | 2022-06-08 | 4 | Greenstreet Yvonne | PCRX | Common Stock | D | 1 160 | 13 247 | ||||||
2022-06-08 | 2022-06-08 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 5 000 | 24 394 | ||||||
2022-06-08 | 2022-06-08 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 7 900 | 19 394 | ||||||
2022-06-08 | 2022-06-06 | 4 | GAUGLER DARYL | PCRX | Common Stock | D | 61,3740 | −1 106 | −68 | 11 494 | ||||
2022-06-08 | 2022-06-08 | 4 | Froimson Mark | PCRX | Common Stock | D | 1 160 | 6 068 | ||||||
2022-06-08 | 2022-06-08 | 4 | CHRISTIE CHRISTOPHER | PCRX | Common Stock | D | 1 160 | 3 486 | ||||||
2022-06-08 | 2022-06-08 | 4 | Brege Laura | PCRX | Common Stock | D | 1 160 | 10 147 | ||||||
2022-05-25 | 2022-05-23 | 4 | SLONIN JONATHAN | PCRX | Stock Option (Right to Buy) | D | 52,37 | −2 000 | 35 500 | |||||
2022-05-25 | 2022-05-23 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 52,3700 | 2 000 | 105 | 28 559 | ||||
2022-05-11 | 3 | GAUGLER DARYL | PCRX | Common Stock | D | 12 600 | ||||||||
2022-05-11 | 2022-05-09 | 4 | Froimson Mark | PCRX | Common Stock | D | 59,3700 | −1 000 | −59 | 4 908 | ||||
2022-05-02 | 2022-04-28 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −22 500 | 0 | |||||
2022-05-02 | 2022-04-28 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 22 500 | 243 | 168 044 | ||||
2022-04-25 | 2022-04-21 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 42,54 | −12 500 | 100 000 | |||||
2022-04-25 | 2022-04-21 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 73,2540 | −9 824 | −720 | 29 650 | ||||
2022-04-25 | 2022-04-21 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 42,5400 | 12 500 | 532 | 39 474 | ||||
2022-04-20 | 2022-04-20 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 42,54 | −12 500 | 112 500 | |||||
2022-04-20 | 2022-04-20 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 73,9900 | −9 764 | −722 | 26 974 | ||||
2022-04-20 | 2022-04-20 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 42,5400 | 12 500 | 532 | 36 738 | ||||
2022-04-20 | 2022-04-19 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 42,54 | −12 500 | 125 000 | |||||
2022-04-20 | 2022-04-19 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 72,2500 | −9 321 | −673 | 24 238 | ||||
2022-04-20 | 2022-04-19 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 42,5400 | 12 500 | 532 | 33 559 | ||||
2022-04-20 | 2022-04-18 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 42,54 | −12 500 | 137 500 | |||||
2022-04-20 | 2022-04-18 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 73,5500 | −8 941 | −658 | 21 059 | ||||
2022-04-20 | 2022-04-18 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 42,5400 | 12 500 | 532 | 30 000 | ||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Stock Option (Right to Buy) | D | 38,35 | −7 000 | 1 750 | |||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Stock Option (Right to Buy) | D | 34,38 | −2 500 | 625 | |||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Stock Option (Right to Buy) | D | 44,20 | −10 000 | 0 | |||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Stock Option (Right to Buy) | D | 40,34 | −3 000 | 0 | |||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 77,9400 | −2 503 | −195 | 17 550 | ||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 77,0300 | −3 937 | −303 | 20 053 | ||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 76,0300 | −16 060 | −1 221 | 23 990 | ||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 38,3500 | 7 000 | 268 | 40 050 | ||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 34,3750 | 2 500 | 86 | 33 050 | ||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 44,2000 | 10 000 | 442 | 30 550 | ||||
2022-04-08 | 2022-04-06 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 40,3400 | 3 000 | 121 | 20 550 | ||||
2022-04-05 | 2022-03-31 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −22 500 | 22 500 | |||||
2022-04-05 | 2022-03-31 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 22 500 | 243 | 145 544 | ||||
2022-03-23 | 2022-03-21 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 47,65 | −2 188 | 19 685 | |||||
2022-03-23 | 2022-03-21 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 43,54 | −2 112 | 10 560 | |||||
2022-03-23 | 2022-03-21 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −2 953 | 2 953 | |||||
2022-03-23 | 2022-03-21 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 72,6700 | −7 253 | −527 | 22 268 | ||||
2022-03-23 | 2022-03-21 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 47,6500 | 2 188 | 104 | 29 521 | ||||
2022-03-23 | 2022-03-21 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 43,5400 | 2 112 | 92 | 27 333 | ||||
2022-03-23 | 2022-03-21 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 2 953 | 113 | 25 221 | ||||
2022-03-14 | 2022-03-10 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −9 300 | 0 | |||||
2022-03-14 | 2022-03-10 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 71,9500 | −900 | −65 | 15 152 | ||||
2022-03-14 | 2022-03-10 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 71,1400 | −8 400 | −598 | 16 052 | ||||
2022-03-14 | 2022-03-10 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 9 300 | 101 | 24 452 | ||||
2022-03-07 | 2022-03-03 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 10,81 | −7 000 | 0 | |||||
2022-03-07 | 2022-03-03 | 4 | PACE GARY W | PCRX | Common Stock | D | 10,8100 | 7 000 | 76 | 136 530 | ||||
2022-03-07 | 2022-03-03 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 10,81 | −7 000 | 0 | |||||
2022-03-07 | 2022-03-03 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 71,7350 | −7 000 | −502 | 18 823 | ||||
2022-03-07 | 2022-03-03 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 10,8100 | 7 000 | 76 | 25 823 | ||||
2022-03-01 | 2022-03-01 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 11,02 | −1 166 | 0 | |||||
2022-03-01 | 2022-03-01 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 11,02 | −193 | 0 | |||||
2022-03-01 | 2022-03-01 | 4 | PACE GARY W | PCRX | Common Stock | D | 67,7500 | −1 359 | −92 | 129 530 | ||||
2022-03-01 | 2022-03-01 | 4 | PACE GARY W | PCRX | Common Stock | D | 11,0200 | 1 166 | 13 | 130 889 | ||||
2022-03-01 | 2022-03-01 | 4 | PACE GARY W | PCRX | Common Stock | D | 11,0200 | 193 | 2 | 129 723 | ||||
2022-03-01 | 2022-02-28 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 11,02 | −18 834 | 1 166 | |||||
2022-03-01 | 2022-02-28 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 11,02 | −9 807 | 193 | |||||
2022-03-01 | 2022-02-28 | 4 | PACE GARY W | PCRX | Common Stock | D | 66,8300 | −28 641 | −1 914 | 129 530 | ||||
2022-03-01 | 2022-02-28 | 4 | PACE GARY W | PCRX | Common Stock | D | 11,0200 | 18 834 | 208 | 158 171 | ||||
2022-03-01 | 2022-02-28 | 4 | PACE GARY W | PCRX | Common Stock | D | 11,0200 | 9 807 | 108 | 139 337 | ||||
2022-03-01 | 2022-02-25 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −2 050 | 5 906 | |||||
2022-03-01 | 2022-02-25 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 67,0700 | −2 000 | −134 | 22 268 | ||||
2022-03-01 | 2022-02-25 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 65,0000 | −50 | −3 | 24 268 | ||||
2022-03-01 | 2022-02-25 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 2 050 | 79 | 24 318 | ||||
2022-03-01 | 2022-02-16 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −10 | 7 956 | |||||
2022-03-01 | 2022-02-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 65,0000 | −10 | −1 | 22 268 | ||||
2022-03-01 | 2022-02-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 10 | 0 | 22 278 | ||||
2022-02-14 | 2022-02-10 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −800 | 7 966 | |||||
2022-02-14 | 2022-02-10 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 65,1800 | −800 | −52 | 22 268 | ||||
2022-02-14 | 2022-02-10 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 800 | 31 | 23 068 | ||||
2022-02-08 | 2022-02-04 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −1 000 | 8 766 | |||||
2022-02-08 | 2022-02-04 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 65,1800 | −1 000 | −65 | 22 268 | ||||
2022-02-08 | 2022-02-04 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 1 000 | 38 | 23 268 | ||||
2022-01-27 | 2022-01-25 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −13 670 | 45 000 | |||||
2022-01-27 | 2022-01-25 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 13 670 | 148 | 123 044 | ||||
2022-01-25 | 2022-01-21 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −200 | 9 766 | |||||
2022-01-25 | 2022-01-21 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 65,4100 | −200 | −13 | 22 268 | ||||
2022-01-25 | 2022-01-21 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 200 | 8 | 22 468 | ||||
2022-01-20 | 2022-01-19 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −2 199 | 9 966 | |||||
2022-01-20 | 2022-01-19 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 65,5100 | −2 199 | −144 | 22 268 | ||||
2022-01-20 | 2022-01-19 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 2 199 | 84 | 24 467 | ||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 47,65 | −13 127 | 21 873 | |||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 43,54 | −6 338 | 12 672 | |||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −2 600 | 12 165 | |||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 44,20 | −1 375 | 0 | |||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 66,1400 | −400 | −26 | 22 268 | ||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 65,2400 | −23 040 | −1 503 | 22 668 | ||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 47,6500 | 13 127 | 626 | 45 708 | ||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 43,5400 | 6 338 | 276 | 32 581 | ||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 2 600 | 100 | 26 243 | ||||
2022-01-20 | 2022-01-18 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 44,2000 | 1 375 | 61 | 23 643 | ||||
2022-01-20 | 2022-01-18 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −2 500 | 9 300 | |||||
2022-01-20 | 2022-01-18 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 64,9720 | −2 500 | −162 | 15 152 | ||||
2022-01-20 | 2022-01-18 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 2 500 | 27 | 17 652 | ||||
2022-01-20 | 2022-01-18 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 63,5500 | −224 | −14 | 17 550 | ||||
2022-01-13 | 2022-01-11 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −15 000 | 58 670 | |||||
2022-01-13 | 2022-01-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 15 000 | 162 | 109 374 | ||||
2022-01-10 | 2022-01-04 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 61,60 | 5 000 | 5 000 | |||||
2022-01-10 | 2022-01-04 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 2 000 | 15 152 | ||||||
2022-01-10 | 2022-01-04 | 4 | MOLLOY ANTHONY | PCRX | Stock Option (Right to Buy) | D | 61,60 | 5 000 | 5 000 | |||||
2022-01-10 | 2022-01-04 | 4 | MOLLOY ANTHONY | PCRX | Common Stock | D | 2 000 | 17 774 | ||||||
2021-12-20 | 2021-12-17 | 4 | Froimson Mark | PCRX | Common Stock | D | −400 | 5 908 | ||||||
2021-12-17 | 3 | MOLLOY ANTHONY | PCRX | Common Stock | D | 15 550 | ||||||||
2021-11-24 | 2021-11-22 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 44,10 | −7 500 | 0 | |||||
2021-11-24 | 2021-11-22 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 44,1000 | 7 500 | 331 | 33 602 | ||||
2021-11-18 | 2021-11-16 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −15 000 | 73 670 | |||||
2021-11-18 | 2021-11-16 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 15 000 | 162 | 94 085 | ||||
2021-11-08 | 2021-11-04 | 4 | WINSTON ROY | PCRX | Stock Option (Right to Buy) | D | 48,15 | −10 000 | 15 000 | |||||
2021-11-08 | 2021-11-04 | 4 | WINSTON ROY | PCRX | Common Stock | D | 48,1500 | 10 000 | 482 | 46 456 | ||||
2021-08-05 | 2021-08-03 | 4 | WINSTON ROY | PCRX | Stock Option (Right to Buy) | D | 60,79 | 10 000 | 10 000 | |||||
2021-08-05 | 2021-08-03 | 4 | WINSTON ROY | PCRX | Common Stock | D | 5 000 | 36 456 | ||||||
2021-08-05 | 2021-08-03 | 4 | SLONIN JONATHAN | PCRX | Stock Option (Right to Buy) | D | 60,79 | 10 000 | 10 000 | |||||
2021-08-05 | 2021-08-03 | 4 | SLONIN JONATHAN | PCRX | Common Stock | D | 5 000 | 26 350 | ||||||
2021-07-30 | 2021-07-29 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −90 | 11 800 | |||||
2021-07-30 | 2021-07-29 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 60,8100 | −90 | −5 | 13 152 | ||||
2021-07-30 | 2021-07-29 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 90 | 1 | 13 242 | ||||
2021-07-30 | 2021-07-28 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −2 410 | 11 890 | |||||
2021-07-30 | 2021-07-28 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 60,8500 | −2 410 | −147 | 13 152 | ||||
2021-07-30 | 2021-07-28 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 2 410 | 26 | 15 562 | ||||
2021-07-30 | 3 | SLONIN JONATHAN | PCRX | Common Stock | D | 21 350 | ||||||||
2021-07-06 | 2021-07-02 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 59,7600 | −421 | −25 | 17 500 | ||||
2021-06-11 | 2021-06-09 | 4 | McLoughlin Dennis | PCRX | Stock Option (Right to Buy) | D | 60,96 | 15 000 | 15 000 | |||||
2021-06-11 | 2021-06-09 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 6 000 | 33 541 | ||||||
2021-06-11 | 2021-06-09 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 60,96 | 7 626 | 7 626 | |||||
2021-06-11 | 2021-06-09 | 4 | PACE GARY W | PCRX | Common Stock | D | 1 066 | 129 530 | ||||||
2021-06-11 | 2021-05-13 | 4 | PACE GARY W | PCRX | Common Stock | D | −1 485 | 128 464 | ||||||
2021-06-11 | 2021-06-09 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 60,96 | 17 500 | 17 500 | |||||
2021-06-11 | 2021-06-09 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 7 000 | 17 500 | ||||||
2021-06-11 | 2021-06-09 | 4 | Reinhart Charles A. III | PCRX | Stock Option (Right to Buy) | D | 60,96 | 15 000 | 15 000 | |||||
2021-06-11 | 2021-06-09 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 6 000 | 30 799 | ||||||
2021-06-11 | 2021-06-09 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 60,96 | 133 400 | 133 400 | |||||
2021-06-11 | 2021-06-09 | 4 | STACK DAVID M | PCRX | Common Stock | D | 17 800 | 78 956 | ||||||
2021-06-11 | 2021-06-11 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 59,8500 | −2 003 | −120 | 12 731 | ||||
2021-06-11 | 2021-06-09 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 60,96 | 6 500 | 6 500 | |||||
2021-06-11 | 2021-06-09 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 2 600 | 14 734 | ||||||
2021-06-11 | 2021-06-09 | 4 | WINSTON ROY | PCRX | Stock Option (Right to Buy) | D | 60,96 | 17 500 | 17 500 | |||||
2021-06-11 | 2021-06-09 | 4 | WINSTON ROY | PCRX | Common Stock | D | 7 000 | 31 035 | ||||||
2021-06-11 | 2021-06-10 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 60,5700 | −847 | −51 | 22 268 | ||||
2021-06-11 | 2021-06-10 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 59,4300 | −4 842 | −288 | 23 115 | ||||
2021-06-11 | 2021-06-09 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 60,96 | 17 500 | 17 500 | |||||
2021-06-11 | 2021-06-09 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 7 000 | 27 957 | ||||||
2021-06-11 | 2021-06-09 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 60,96 | 7 626 | 7 626 | |||||
2021-06-11 | 2021-06-09 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1 066 | 18 823 | ||||||
2021-06-11 | 2021-06-09 | 4 | Manning Donald C. | PCRX | Stock Option (Right to Buy) | D | 60,96 | 15 000 | 15 000 | |||||
2021-06-11 | 2021-06-09 | 4 | Manning Donald C. | PCRX | Common Stock | D | 6 000 | 29 520 | ||||||
2021-06-11 | 2021-06-09 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 60,96 | 7 626 | 7 626 | |||||
2021-06-11 | 2021-06-09 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 1 066 | 16 737 | ||||||
2021-06-11 | 2021-06-09 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 60,96 | 17 500 | 17 500 | |||||
2021-06-11 | 2021-06-09 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 7 000 | 25 681 | ||||||
2021-06-11 | 2021-06-09 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 60,96 | 7 626 | 7 626 | |||||
2021-06-11 | 2021-06-09 | 4 | Greenstreet Yvonne | PCRX | Common Stock | D | 1 066 | 12 087 | ||||||
2021-06-11 | 2021-06-09 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 60,96 | 7 626 | 7 626 | |||||
2021-06-11 | 2021-06-09 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 1 066 | 6 552 | ||||||
2021-06-11 | 2021-06-09 | 4 | CHRISTIE CHRISTOPHER | PCRX | Stock Option (Right to Buy) | D | 60,96 | 7 626 | 7 626 | |||||
2021-06-11 | 2021-06-09 | 4 | CHRISTIE CHRISTOPHER | PCRX | Common Stock | D | 1 066 | 2 326 | ||||||
2021-06-11 | 2021-06-09 | 4 | Froimson Mark | PCRX | Stock Option (Right to Buy) | D | 60,96 | 7 626 | 7 626 | |||||
2021-06-11 | 2021-06-09 | 4 | Froimson Mark | PCRX | Common Stock | D | 1 066 | 6 308 | ||||||
2021-06-11 | 2021-06-09 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 60,96 | 7 626 | 7 626 | |||||
2021-06-11 | 2021-06-09 | 4 | Brege Laura | PCRX | Common Stock | D | 1 066 | 8 987 | ||||||
2021-06-10 | 2021-06-08 | 4 | Manning Donald C. | PCRX | Common Stock | D | 61,1400 | −2 600 | −159 | 23 520 | ||||
2021-06-08 | 2021-06-04 | 4 | WINSTON ROY | PCRX | Common Stock | D | 61,0370 | −2 276 | −139 | 24 035 | ||||
2021-06-08 | 2021-06-04 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 61,0370 | −3 930 | −240 | 20 957 | ||||
2021-06-08 | 2021-06-04 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 61,0370 | −1 047 | −64 | 12 134 | ||||
2021-06-08 | 2021-06-04 | 4 | STACK DAVID M | PCRX | Common Stock | D | 61,0370 | −14 905 | −910 | 61 156 | ||||
2021-06-08 | 2021-06-07 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 60,5000 | −2 278 | −138 | 10 500 | ||||
2021-06-08 | 2021-06-04 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 61,0370 | −1 222 | −75 | 12 778 | ||||
2021-06-08 | 2021-06-04 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 61,0370 | −2 648 | −162 | 24 799 | ||||
2021-06-08 | 2021-06-04 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 61,0370 | −1 895 | −116 | 27 541 | ||||
2021-06-08 | 2021-06-04 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 61,0370 | −2 117 | −129 | 18 681 | ||||
2021-06-08 | 2021-06-04 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 62,1900 | −630 | −39 | 5 486 | ||||
2021-06-04 | 2021-06-02 | 4 | Manning Donald C. | PCRX | Common Stock | D | 62,1230 | −2 380 | −148 | 26 120 | ||||
2021-05-13 | 2021-05-12 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −21 250 | 88 670 | |||||
2021-05-13 | 2021-05-12 | 4 | STACK DAVID M | PCRX | Common Stock | D | 62,4100 | −3 611 | −225 | 76 061 | ||||
2021-05-13 | 2021-05-12 | 4 | STACK DAVID M | PCRX | Common Stock | D | 62,0800 | −14 669 | −911 | 79 672 | ||||
2021-05-13 | 2021-05-12 | 4 | STACK DAVID M | PCRX | Common Stock | D | 60,7600 | −2 970 | −180 | 94 341 | ||||
2021-05-13 | 2021-05-12 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 21 250 | 230 | 97 311 | ||||
2021-05-13 | 2021-05-11 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −21 250 | 109 920 | |||||
2021-05-13 | 2021-05-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 61,1900 | −7 932 | −485 | 76 061 | ||||
2021-05-13 | 2021-05-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 60,7800 | −13 318 | −809 | 83 993 | ||||
2021-05-13 | 2021-05-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 21 250 | 230 | 97 311 | ||||
2021-05-13 | 2021-03-24 | 4 | STACK DAVID M By Three Colleens Investment, LLC | PCRX | Common Stock | I | −1 080 | 97 273 | ||||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 43,54 | −6 339 | 19 010 | |||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −8 859 | 14 765 | |||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 44,20 | −4 125 | 1 375 | |||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 32,35 | −2 500 | 0 | |||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 68,1100 | −7 030 | −479 | 24 887 | ||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 66,4000 | −14 793 | −982 | 31 917 | ||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 43,5400 | 6 339 | 276 | 46 710 | ||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 8 859 | 340 | 40 371 | ||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 44,2000 | 4 125 | 182 | 31 512 | ||||
2021-04-15 | 2021-04-13 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 32,3500 | 2 500 | 81 | 27 387 | ||||
2021-04-02 | 2021-03-31 | 4 | WINSTON ROY | PCRX | Stock Option (Right to Buy) | D | 34,38 | −13 750 | 6 250 | |||||
2021-04-02 | 2021-03-31 | 4 | WINSTON ROY | PCRX | Common Stock | D | 72,1200 | −1 200 | −87 | 26 311 | ||||
2021-04-02 | 2021-03-31 | 4 | WINSTON ROY | PCRX | Common Stock | D | 71,0900 | −4 661 | −331 | 27 511 | ||||
2021-04-02 | 2021-03-31 | 4 | WINSTON ROY | PCRX | Common Stock | D | 70,3600 | −16 363 | −1 151 | 32 172 | ||||
2021-04-02 | 2021-03-31 | 4 | WINSTON ROY | PCRX | Common Stock | D | 34,3750 | 13 750 | 473 | 48 535 | ||||
2021-03-17 | 2021-03-17 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −2 000 | 14 300 | |||||
2021-03-17 | 2021-03-17 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 70,0100 | −2 000 | −140 | 13 181 | ||||
2021-03-17 | 2021-03-17 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 2 000 | 22 | 15 181 | ||||
2021-03-17 | 2021-03-15 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −1 520 | 16 300 | |||||
2021-03-17 | 2021-03-15 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 73,2800 | −1 520 | −111 | 13 181 | ||||
2021-03-17 | 2021-03-15 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 1 520 | 16 | 14 701 | ||||
2021-03-17 | 2021-03-15 | 4 | Froimson Mark | PCRX | Common Stock | D | 72,2600 | −734 | −53 | 5 242 | ||||
2021-03-16 | 2021-03-15 | 4 | Wicki Andreas | PCRX | Common Stock | I | 73,6800 | −10 601 | −781 | 451 324 | ||||
2021-03-16 | 2021-03-12 | 4 | Wicki Andreas | PCRX | Common Stock | I | 73,1000 | −58 754 | −4 295 | 461 925 | ||||
2021-03-11 | 2021-03-11 | 4 | Wicki Andreas | PCRX | Common Stock | I | 72,7000 | −60 574 | −4 404 | 520 679 | ||||
2021-03-11 | 2021-03-10 | 4 | Wicki Andreas | PCRX | Common Stock | I | 71,7800 | −76 480 | −5 490 | 581 253 | ||||
2021-03-11 | 2021-03-09 | 4 | Wicki Andreas | PCRX | Common Stock | I | 70,9000 | −35 137 | −2 491 | 657 733 | ||||
2021-03-09 | 2021-03-05 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 13,98 | −3 000 | 0 | |||||
2021-03-09 | 2021-03-05 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 65,8800 | −3 000 | −198 | 6 116 | ||||
2021-03-09 | 2021-03-05 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 13,9800 | 3 000 | 42 | 9 116 | ||||
2021-03-03 | 2021-03-01 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 13,98 | −5 000 | 0 | |||||
2021-03-03 | 2021-03-01 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 72,2600 | −5 000 | −361 | 17 757 | ||||
2021-03-03 | 2021-03-01 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 13,9800 | 5 000 | 70 | 22 757 | ||||
2021-02-04 | 2021-02-03 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −21 250 | 131 170 | |||||
2021-02-04 | 2021-02-03 | 4 | STACK DAVID M | PCRX | Common Stock | D | 71,4200 | −14 350 | −1 025 | 76 061 | ||||
2021-02-04 | 2021-02-03 | 4 | STACK DAVID M | PCRX | Common Stock | D | 70,7800 | −6 900 | −488 | 90 411 | ||||
2021-02-04 | 2021-02-03 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 21 250 | 230 | 97 311 | ||||
2021-02-04 | 2021-02-02 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −21 250 | 152 420 | |||||
2021-02-04 | 2021-02-02 | 4 | STACK DAVID M | PCRX | Common Stock | D | 70,2000 | −4 100 | −288 | 76 061 | ||||
2021-02-04 | 2021-02-02 | 4 | STACK DAVID M | PCRX | Common Stock | D | 69,3800 | −14 250 | −989 | 80 161 | ||||
2021-02-04 | 2021-02-02 | 4 | STACK DAVID M | PCRX | Common Stock | D | 68,4100 | −2 900 | −198 | 94 411 | ||||
2021-02-04 | 2021-02-02 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 21 250 | 230 | 97 311 | ||||
2021-01-08 | 2021-01-06 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 60,8100 | −110 | −7 | 14 000 | ||||
2020-11-17 | 2020-11-13 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −3 000 | 17 820 | |||||
2020-11-17 | 2020-11-13 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 63,8100 | −3 000 | −191 | 13 181 | ||||
2020-11-17 | 2020-11-13 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 3 000 | 32 | 16 181 | ||||
2020-11-17 | 2020-11-16 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 13,98 | −12 000 | 0 | |||||
2020-11-17 | 2020-11-16 | 4 | Brege Laura | PCRX | Common Stock | D | 65,9500 | −12 000 | −791 | 7 921 | ||||
2020-11-17 | 2020-11-16 | 4 | Brege Laura | PCRX | Common Stock | D | 13,9800 | 12 000 | 168 | 19 921 | ||||
2020-11-17 | 2020-11-13 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 42,54 | −25 000 | 150 000 | |||||
2020-11-17 | 2020-11-13 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 63,5100 | −21 000 | −1 334 | 14 000 | ||||
2020-11-17 | 2020-11-13 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 62,6700 | −4 000 | −251 | 35 000 | ||||
2020-11-17 | 2020-11-13 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 42,5400 | 25 000 | 1 064 | 39 000 | ||||
2020-11-17 | 2020-11-13 | 4 | WINSTON ROY | PCRX | Common Stock | D | 62,0000 | −5 000 | −310 | 34 785 | ||||
2020-10-16 | 2020-10-16 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −30 000 | 173 670 | |||||
2020-10-16 | 2020-10-16 | 4 | STACK DAVID M | PCRX | Common Stock | D | 55,5600 | −30 000 | −1 667 | 173 377 | ||||
2020-10-16 | 2020-10-16 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 30 000 | 324 | 203 377 | ||||
2020-10-16 | 2020-10-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −30 000 | 203 670 | |||||
2020-10-16 | 2020-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 55,0000 | −30 000 | −1 650 | 173 377 | ||||
2020-10-16 | 2020-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 30 000 | 324 | 203 377 | ||||
2020-10-16 | 2020-10-14 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −30 000 | 233 670 | |||||
2020-10-16 | 2020-10-14 | 4 | STACK DAVID M | PCRX | Common Stock | D | 55,5300 | −30 000 | −1 666 | 173 377 | ||||
2020-10-16 | 2020-10-14 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 30 000 | 324 | 203 377 | ||||
2020-09-29 | 2020-09-25 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 16,67 | −70 000 | 0 | |||||
2020-09-29 | 2020-09-25 | 4 | PACE GARY W | PCRX | Common Stock | D | 16,6700 | 70 000 | 1 167 | 129 949 | ||||
2020-09-21 | 2020-09-17 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 42,54 | −25 000 | 175 000 | |||||
2020-09-21 | 2020-09-17 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 60,2600 | −2 888 | −174 | 14 000 | ||||
2020-09-21 | 2020-09-17 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 59,7500 | −22 532 | −1 346 | 16 888 | ||||
2020-09-21 | 2020-09-17 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 42,5400 | 25 000 | 1 064 | 39 000 | ||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 43,54 | −2 819 | 25 349 | |||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −7 878 | 23 624 | |||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 44,20 | −5 502 | 5 500 | |||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 32,35 | −5 836 | 2 500 | |||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 40,34 | −5 836 | 2 500 | |||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 60,2200 | −3 200 | −193 | 24 887 | ||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 59,7700 | −24 671 | −1 475 | 28 087 | ||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 43,5400 | 2 819 | 123 | 52 758 | ||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 7 878 | 302 | 49 939 | ||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 44,2000 | 5 502 | 243 | 42 061 | ||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 32,3500 | 5 836 | 189 | 36 559 | ||||
2020-09-17 | 2020-09-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 40,3400 | 5 836 | 235 | 30 723 | ||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 43,54 | −2 816 | 28 168 | |||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −7 874 | 31 502 | |||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 44,20 | −5 499 | 11 002 | |||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 32,35 | −5 832 | 8 336 | |||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 40,34 | −5 832 | 8 336 | |||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 60,3300 | −21 244 | −1 282 | 24 887 | ||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 59,5400 | −6 609 | −393 | 46 131 | ||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 43,5400 | 2 816 | 123 | 52 740 | ||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 7 874 | 302 | 49 924 | ||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 44,2000 | 5 499 | 243 | 42 050 | ||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 32,3500 | 5 832 | 189 | 36 551 | ||||
2020-09-17 | 2020-09-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 40,3400 | 5 832 | 235 | 30 719 | ||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 43,54 | −2 816 | 30 984 | |||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | −7 874 | 39 376 | |||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 44,20 | −5 499 | 16 501 | |||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 32,35 | −5 832 | 14 168 | |||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 40,34 | −5 832 | 14 168 | |||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 59,8000 | −13 231 | −791 | 24 887 | ||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 59,0100 | −14 622 | −863 | 38 118 | ||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 43,5400 | 2 816 | 123 | 52 740 | ||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 38,3500 | 7 874 | 302 | 49 924 | ||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 44,2000 | 5 499 | 243 | 42 050 | ||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 32,3500 | 5 832 | 189 | 36 551 | ||||
2020-09-17 | 2020-09-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 40,3400 | 5 832 | 235 | 30 719 | ||||
2020-09-17 | 2020-09-16 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −3 000 | 20 820 | |||||
2020-09-17 | 2020-09-16 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 60,3400 | −3 000 | −181 | 13 181 | ||||
2020-09-17 | 2020-09-16 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 3 000 | 32 | 16 181 | ||||
2020-09-11 | 2020-09-09 | 4 | Wicki Andreas | PCRX | Common Stock | I | 62,0200 | −2 216 | −137 | 692 970 | ||||
2020-08-19 | 2020-08-17 | 4 | STACK DAVID M | PCRX | Common Stock | D | 62,3400 | −3 217 | −201 | 173 377 | ||||
2020-08-19 | 2020-08-17 | 4 | STACK DAVID M | PCRX | Common Stock | D | 61,7900 | −11 783 | −728 | 176 594 | ||||
2020-08-13 | 2020-08-13 | 4 | Wicki Andreas | PCRX | Common Stock | I | 61,4700 | −34 904 | −2 146 | 695 186 | ||||
2020-08-13 | 2020-08-12 | 4 | Wicki Andreas | PCRX | Common Stock | I | 60,8200 | −113 500 | −6 903 | 730 090 | ||||
2020-08-13 | 2020-08-11 | 4 | Wicki Andreas | PCRX | Common Stock | I | 61,9000 | −46 151 | −2 857 | 843 590 | ||||
2020-08-13 | 2020-08-11 | 4 | Wicki Andreas | PCRX | Common Stock | I | 60,8700 | −60 621 | −3 690 | 889 741 | ||||
2020-08-13 | 2020-08-11 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,34 | −8 180 | 0 | |||||
2020-08-13 | 2020-08-11 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 60,5000 | −8 180 | −495 | 13 181 | ||||
2020-08-13 | 2020-08-11 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 8 180 | 85 | 20 813 | ||||
2020-08-05 | 2020-08-03 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 44,10 | −2 500 | 7 500 | |||||
2020-08-05 | 2020-08-03 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 52,6800 | −2 500 | −132 | 20 796 | ||||
2020-08-05 | 2020-08-03 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 44,1000 | 2 500 | 110 | 22 750 | ||||
2020-07-17 | 2020-07-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 56,8800 | −12 000 | −683 | 188 377 | ||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 44,10 | −30 000 | 10 000 | |||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 43,54 | −7 500 | 22 500 | |||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 38,35 | −15 000 | 15 000 | |||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 37,81 | −3 750 | 6 250 | |||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 52,0300 | −1 778 | −93 | 20 250 | ||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 51,7700 | −6 859 | −355 | 22 028 | ||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 50,0100 | −51 464 | −2 574 | 28 887 | ||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 44,1000 | 30 000 | 1 323 | 80 351 | ||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 43,5400 | 7 500 | 327 | 50 351 | ||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 38,3500 | 15 000 | 575 | 42 851 | ||||
2020-07-01 | 2020-06-29 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 37,8100 | 3 750 | 142 | 27 851 | ||||
2020-07-01 | 2020-06-29 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,34 | −6 000 | 8 180 | |||||
2020-07-01 | 2020-06-29 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 50,3400 | −2 000 | −101 | 12 633 | ||||
2020-07-01 | 2020-06-29 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 49,3400 | −2 000 | −99 | 14 633 | ||||
2020-07-01 | 2020-06-29 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 48,7200 | −2 000 | −97 | 16 633 | ||||
2020-07-01 | 2020-06-29 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 6 000 | 62 | 18 633 | ||||
2020-06-11 | 2020-06-09 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 47,65 | 12 000 | 12 000 | |||||
2020-06-11 | 2020-06-09 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 4 800 | 12 633 | ||||||
2020-06-11 | 2020-06-09 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 47,65 | 275 000 | 275 000 | |||||
2020-06-11 | 2020-06-09 | 4 | STACK DAVID M | PCRX | Common Stock | D | 33 300 | 200 209 | ||||||
2020-06-11 | 2020-06-09 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 47,65 | 35 000 | 35 000 | |||||
2020-06-11 | 2020-06-09 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 14 000 | 24 887 | ||||||
2020-06-11 | 2020-06-09 | 4 | WINSTON ROY | PCRX | Stock Option (Right to Buy) | D | 47,65 | 35 000 | 35 000 | |||||
2020-06-11 | 2020-06-09 | 4 | WINSTON ROY | PCRX | Common Stock | D | 14 000 | 39 237 | ||||||
2020-06-11 | 2020-06-09 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 47,65 | 8 027 | 8 027 | |||||
2020-06-11 | 2020-06-09 | 4 | PACE GARY W | PCRX | Common Stock | D | 1 260 | 59 949 | ||||||
2020-06-11 | 2020-06-09 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 47,65 | 35 000 | 35 000 | |||||
2020-06-11 | 2020-06-09 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 14 000 | 24 101 | ||||||
2020-06-11 | 2020-06-09 | 4 | McLoughlin Dennis | PCRX | Stock Option (Right to Buy) | D | 47,65 | 35 000 | 35 000 | |||||
2020-06-11 | 2020-06-09 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 14 000 | 28 898 | ||||||
2020-06-11 | 2020-06-09 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 47,65 | 35 000 | 35 000 | |||||
2020-06-11 | 2020-06-09 | 4 | REINHARDT MAX | PCRX | Common Stock | D | 14 000 | 14 000 | ||||||
2020-06-11 | 2020-06-09 | 4 | Reinhart Charles A. III | PCRX | Stock Option (Right to Buy) | D | 47,65 | 31 500 | 31 500 | |||||
2020-06-11 | 2020-06-09 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 12 600 | 27 447 | ||||||
2020-06-11 | 2020-06-09 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 47,65 | 8 027 | 8 027 | |||||
2020-06-11 | 2020-06-09 | 4 | Brege Laura | PCRX | Common Stock | D | 1 260 | 7 921 | ||||||
2020-06-11 | 2020-06-09 | 4 | CHRISTIE CHRISTOPHER | PCRX | Stock Option (Right to Buy) | D | 47,65 | 8 027 | 8 027 | |||||
2020-06-11 | 2020-06-09 | 4 | CHRISTIE CHRISTOPHER | PCRX | Common Stock | D | 1 260 | 1 260 | ||||||
2020-06-11 | 2020-06-09 | 4 | Froimson Mark | PCRX | Stock Option (Right to Buy) | D | 47,65 | 8 027 | 8 027 | |||||
2020-06-11 | 2020-06-09 | 4 | Froimson Mark | PCRX | Common Stock | D | 1 260 | 5 976 | ||||||
2020-06-11 | 2020-06-09 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 47,65 | 8 027 | 8 027 | |||||
2020-06-11 | 2020-06-09 | 4 | Greenstreet Yvonne | PCRX | Common Stock | D | 1 260 | 11 021 | ||||||
2020-06-11 | 2020-06-09 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 47,65 | 8 027 | 8 027 | |||||
2020-06-11 | 2020-06-09 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 1 260 | 6 116 | ||||||
2020-06-11 | 2020-06-09 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 47,65 | 8 027 | 8 027 | |||||
2020-06-11 | 2020-06-09 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 1 260 | 15 671 | ||||||
2020-06-11 | 2020-06-09 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 47,65 | 8 027 | 8 027 | |||||
2020-06-11 | 2020-06-09 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1 260 | 17 757 | ||||||
2020-06-08 | 2020-06-05 | 4 | Brege Laura | PCRX | Common Stock | D | 48,7000 | −2 100 | −102 | 6 661 | ||||
2020-06-08 | 2020-06-04 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 47,4600 | −2 025 | −96 | 4 856 | ||||
2020-06-08 | 2020-06-04 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 46,3310 | −863 | −40 | 10 101 | ||||
2020-06-08 | 2020-06-04 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 46,3310 | −1 447 | −67 | 14 898 | ||||
2020-06-08 | 2020-06-04 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 46,3310 | −1 489 | −69 | 14 847 | ||||
2020-06-08 | 2020-06-05 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 48,3700 | −1 752 | −85 | 7 833 | ||||
2020-06-08 | 2020-06-04 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 46,3310 | −879 | −41 | 9 585 | ||||
2020-06-08 | 2020-06-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 48,4900 | −1 721 | −83 | 166 909 | ||||
2020-06-08 | 2020-06-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 48,0800 | −15 390 | −740 | 168 630 | ||||
2020-06-08 | 2020-06-04 | 4 | STACK DAVID M | PCRX | Common Stock | D | 46,3310 | −14 314 | −663 | 184 020 | ||||
2020-06-08 | 2020-06-05 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 48,6100 | −5 904 | −287 | 10 887 | ||||
2020-06-08 | 2020-06-04 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 46,3310 | −2 402 | −111 | 16 791 | ||||
2020-06-04 | 2020-06-02 | 4 | Manning Donald C. | PCRX | Stock Option (Right to Buy) | D | 43,58 | 71 300 | 71 300 | |||||
2020-06-04 | 2020-06-02 | 4 | Manning Donald C. | PCRX | Common Stock | D | 28 500 | 28 500 | ||||||
2020-05-21 | 2020-05-21 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,34 | −2 000 | 14 180 | |||||
2020-05-21 | 2020-05-21 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 45,2600 | −2 000 | −91 | 10 464 | ||||
2020-05-21 | 2020-05-21 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 2 000 | 21 | 12 464 | ||||
2020-05-21 | 2020-05-19 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,34 | −2 000 | 16 180 | |||||
2020-05-21 | 2020-05-19 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 42,8100 | −2 000 | −86 | 10 464 | ||||
2020-05-21 | 2020-05-19 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 2 000 | 21 | 12 464 | ||||
2020-03-16 | 2020-03-12 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 1,61 | −3 736 | 0 | |||||
2020-03-16 | 2020-03-12 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 3 736 | 6 | 16 497 | ||||
2020-03-16 | 2020-03-12 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 13,98 | −5 000 | 0 | |||||
2020-03-16 | 2020-03-12 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 1,61 | −7 438 | 0 | |||||
2020-03-16 | 2020-03-12 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 1,61 | −4 649 | 0 | |||||
2020-03-16 | 2020-03-12 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 1,61 | −4 649 | 0 | |||||
2020-03-16 | 2020-03-12 | 4 | PACE GARY W | PCRX | Common Stock | D | 13,9800 | 5 000 | 70 | 58 689 | ||||
2020-03-16 | 2020-03-12 | 4 | PACE GARY W | PCRX | Common Stock | D | 1,6100 | 7 438 | 12 | 53 689 | ||||
2020-03-16 | 2020-03-12 | 4 | PACE GARY W | PCRX | Common Stock | D | 1,6100 | 4 649 | 7 | 46 251 | ||||
2020-03-16 | 2020-03-12 | 4 | PACE GARY W | PCRX | Common Stock | D | 1,6100 | 4 649 | 7 | 46 251 | ||||
2020-03-12 | 2020-03-11 | 4 | WINSTON ROY | PCRX | Common Stock | D | 36,5000 | 2 500 | 91 | 25 237 | ||||
2020-02-25 | 2020-02-21 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −16 356 | 0 | |||||
2020-02-25 | 2020-02-21 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −19 500 | 0 | |||||
2020-02-25 | 2020-02-21 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 16 356 | 90 | 198 334 | ||||
2020-02-25 | 2020-02-21 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 19 500 | 31 | 181 978 | ||||
2020-02-12 | 2020-02-10 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −3 000 | 23 820 | |||||
2020-02-12 | 2020-02-10 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 49,8100 | −1 000 | −50 | 10 464 | ||||
2020-02-12 | 2020-02-10 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 48,8100 | −1 000 | −49 | 11 464 | ||||
2020-02-12 | 2020-02-10 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 47,8100 | −1 000 | −48 | 12 464 | ||||
2020-02-12 | 2020-02-10 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 3 000 | 32 | 13 464 | ||||
2020-02-10 | 2020-02-07 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −170 | 26 820 | |||||
2020-02-10 | 2020-02-07 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 46,8100 | −170 | −8 | 10 464 | ||||
2020-02-10 | 2020-02-07 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 170 | 2 | 10 634 | ||||
2020-02-10 | 2020-02-06 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −830 | 26 990 | |||||
2020-02-10 | 2020-02-06 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 46,8100 | −830 | −39 | 10 464 | ||||
2020-02-10 | 2020-02-06 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 830 | 9 | 11 294 | ||||
2020-01-17 | 2020-01-15 | 4 | STACK DAVID M By LCK Investment LLC | PCRX | Stock Option (Right to Buy) | I | 10,81 | −25 000 | 243 129 | |||||
2020-01-17 | 2020-01-15 | 4 | STACK DAVID M By LCK Investment LLC | PCRX | Common Stock | I | 43,4800 | −1 975 | −86 | 1 208 | ||||
2020-01-17 | 2020-01-15 | 4 | STACK DAVID M By LCK Investment LLC | PCRX | Common Stock | I | 42,6100 | −23 025 | −981 | 3 183 | ||||
2020-01-17 | 2020-01-15 | 4 | STACK DAVID M By LCK Investment LLC | PCRX | Common Stock | I | 10,8100 | 25 000 | 270 | 26 208 | ||||
2019-12-30 | 2019-12-26 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −10 000 | 16 356 | |||||
2019-12-30 | 2019-12-26 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −10 000 | 16 356 | |||||
2019-12-30 | 2019-12-26 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 10 000 | 55 | 162 299 | ||||
2019-12-30 | 2019-12-26 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 10 000 | 16 | 152 299 | ||||
2019-12-26 | 2019-12-23 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −1 000 | 27 820 | |||||
2019-12-26 | 2019-12-23 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 45,9200 | −1 000 | −46 | 10 464 | ||||
2019-12-26 | 2019-12-23 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 1 000 | 11 | 11 464 | ||||
2019-12-19 | 2019-12-16 | 4 | Froimson Mark | PCRX | Common Stock | D | −300 | 4 716 | ||||||
2019-12-18 | 2019-12-16 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 45,7935 | −3 671 | −168 | 16 116 | ||||
2019-12-04 | 2019-12-02 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 1,61 | −3 128 | 3 736 | |||||
2019-12-04 | 2019-12-02 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 1,61 | −872 | 0 | |||||
2019-12-04 | 2019-12-02 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 46,1320 | −1 300 | −60 | 12 761 | ||||
2019-12-04 | 2019-12-02 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 3 128 | 5 | 14 061 | ||||
2019-12-04 | 2019-12-02 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 872 | 1 | 10 933 | ||||
2019-11-22 | 2019-11-20 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −1 000 | 28 820 | |||||
2019-11-22 | 2019-11-20 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 44,1400 | −1 176 | −52 | 10 464 | ||||
2019-11-22 | 2019-11-20 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 1 000 | 11 | 11 640 | ||||
2019-11-19 | 2019-11-15 | 4 | STACK DAVID M By LCK Investment LLC | PCRX | Stock Option (Right to Buy) | I | 10,81 | −25 000 | 288 670 | |||||
2019-11-19 | 2019-11-15 | 4 | STACK DAVID M By LCK Investment LLC | PCRX | Common Stock | I | 42,8100 | −25 000 | −1 070 | 1 208 | ||||
2019-11-19 | 2019-11-15 | 4 | STACK DAVID M By LCK Investment LLC | PCRX | Common Stock | I | 10,8100 | 25 000 | 270 | 26 208 | ||||
2019-11-19 | 2019-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 42,8100 | −45 000 | −1 926 | 142 299 | ||||
2019-11-12 | 2019-11-08 | 4 | Scranton Richard | PCRX | Stock Option (Right to Buy) | D | 25,37 | −4 750 | 20 250 | |||||
2019-11-12 | 2019-11-08 | 4 | Scranton Richard | PCRX | Stock Option (Right to Buy) | D | 10,81 | −14 698 | 0 | |||||
2019-11-12 | 2019-11-08 | 4 | Scranton Richard | PCRX | Common Stock | D | 45,0000 | −19 448 | −875 | 16 061 | ||||
2019-11-12 | 2019-11-08 | 4 | Scranton Richard | PCRX | Common Stock | D | 25,3700 | 4 750 | 121 | 35 509 | ||||
2019-11-12 | 2019-11-08 | 4 | Scranton Richard | PCRX | Common Stock | D | 10,8100 | 14 698 | 159 | 30 759 | ||||
2019-11-12 | 2019-11-11 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,81 | −180 | 29 820 | |||||
2019-11-12 | 2019-11-11 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,34 | −4 820 | 18 180 | |||||
2019-11-12 | 2019-11-11 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 43,5900 | −5 000 | −218 | 10 640 | ||||
2019-11-12 | 2019-11-11 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,8100 | 180 | 2 | 15 640 | ||||
2019-11-12 | 2019-11-11 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 4 820 | 50 | 15 460 | ||||
2019-10-04 | 2019-10-02 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 549,00 | −10 000 | 26 356 | |||||
2019-10-04 | 2019-10-02 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −7 000 | 29 500 | |||||
2019-10-04 | 2019-10-02 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 10 000 | 55 | 187 299 | ||||
2019-10-04 | 2019-10-02 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 7 000 | 11 | 177 299 | ||||
2019-09-20 | 2019-09-18 | 4 | CHRISTIE CHRISTOPHER | PCRX | Stock Option (Right to Buy) | D | 37,16 | 19 919 | 19 919 | |||||
2019-09-20 | 2019-09-18 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −6 500 | 36 356 | |||||
2019-09-20 | 2019-09-18 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −7 500 | 36 500 | |||||
2019-09-20 | 2019-09-18 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 6 500 | 36 | 170 299 | ||||
2019-09-20 | 2019-09-18 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 7 500 | 12 | 163 799 | ||||
2019-08-16 | 2019-08-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −12 849 | 0 | |||||
2019-08-16 | 2019-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 39,6100 | −2 391 | −95 | 156 299 | ||||
2019-08-16 | 2019-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 39,0500 | −10 458 | −408 | 158 690 | ||||
2019-08-16 | 2019-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 12 849 | 139 | 169 148 | ||||
2019-08-16 | 2019-08-14 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 39,4900 | −6 252 | −247 | 19 193 | ||||
2019-07-10 | 2019-07-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 43,4200 | −700 | −30 | 156 299 | ||||
2019-07-10 | 2019-07-08 | 4 | STACK DAVID M | PCRX | Common Stock | D | 42,8500 | −12 415 | −532 | 156 999 | ||||
2019-07-03 | 2019-07-02 | 4 | REINHARDT MAX | PCRX | Stock Option (Right to Buy) | D | 42,54 | 200 000 | 200 000 | |||||
2019-06-13 | 2019-06-11 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −9 000 | 42 856 | |||||
2019-06-13 | 2019-06-11 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 44 000 | |||||
2019-06-13 | 2019-06-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 9 000 | 49 | 169 231 | ||||
2019-06-13 | 2019-06-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 160 231 | ||||
2019-06-12 | 2019-06-10 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 44,2800 | −2 126 | −94 | 10 042 | ||||
2019-06-06 | 2019-06-05 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 43,54 | 142 100 | 142 100 | |||||
2019-06-06 | 2019-06-05 | 4 | STACK DAVID M | PCRX | Common Stock | D | 23 700 | 145 231 | ||||||
2019-06-06 | 2019-06-04 | 4 | STACK DAVID M | PCRX | Common Stock | D | 42,9100 | −12 385 | −531 | 121 531 | ||||
2019-06-06 | 2019-06-05 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 43,54 | 33 800 | 33 800 | |||||
2019-06-06 | 2019-06-05 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 5 600 | 25 445 | ||||||
2019-06-06 | 2019-06-04 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 42,9100 | −2 529 | −109 | 19 845 | ||||
2019-06-06 | 2019-06-05 | 4 | WINSTON ROY | PCRX | Stock Option (Right to Buy) | D | 43,54 | 33 800 | 33 800 | |||||
2019-06-06 | 2019-06-05 | 4 | WINSTON ROY | PCRX | Common Stock | D | 5 600 | 22 139 | ||||||
2019-06-06 | 2019-06-04 | 4 | WINSTON ROY | PCRX | Common Stock | D | 42,9100 | −722 | −31 | 16 539 | ||||
2019-06-06 | 2019-06-05 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 43,54 | 8 437 | 8 437 | |||||
2019-06-06 | 2019-06-05 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 4 134 | 10 061 | ||||||
2019-06-06 | 2019-06-05 | 4 | McLoughlin Dennis | PCRX | Stock Option (Right to Buy) | D | 43,54 | 33 800 | 33 800 | |||||
2019-06-06 | 2019-06-05 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 5 600 | 19 422 | ||||||
2019-06-06 | 2019-06-04 | 4 | McLoughlin Dennis | PCRX | Common Stock | D | 42,9100 | −1 099 | −47 | 13 822 | ||||
2019-06-06 | 2019-06-05 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 43,54 | 8 437 | 8 437 | |||||
2019-06-06 | 2019-06-05 | 4 | PACE GARY W | PCRX | Common Stock | D | 4 134 | 36 953 | ||||||
2019-06-06 | 2019-06-05 | 4 | Reinhart Charles A. III | PCRX | Stock Option (Right to Buy) | D | 43,54 | 26 300 | 26 300 | |||||
2019-06-06 | 2019-06-05 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 4 400 | 16 336 | ||||||
2019-06-06 | 2019-06-04 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 42,9100 | −1 106 | −47 | 11 936 | ||||
2019-06-06 | 2019-06-05 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 43,54 | 11 200 | 11 200 | |||||
2019-06-06 | 2019-06-05 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 1 900 | 12 168 | ||||||
2019-06-06 | 2019-06-04 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 42,9100 | −967 | −41 | 10 268 | ||||
2019-06-06 | 2019-06-05 | 4 | Scranton Richard | PCRX | Stock Option (Right to Buy) | D | 43,54 | 30 000 | 30 000 | |||||
2019-06-06 | 2019-06-05 | 4 | Scranton Richard | PCRX | Common Stock | D | 5 000 | 16 061 | ||||||
2019-06-06 | 2019-06-05 | 4 | Scranton Richard | PCRX | Common Stock | D | 43,5000 | −4 114 | −179 | 11 061 | ||||
2019-06-06 | 2019-06-04 | 4 | Scranton Richard | PCRX | Common Stock | D | 42,6600 | −2 852 | −122 | 15 175 | ||||
2019-06-06 | 2019-06-04 | 4 | Scranton Richard | PCRX | Common Stock | D | 42,9100 | −2 074 | −89 | 18 027 | ||||
2019-06-06 | 2019-06-05 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 43,54 | 8 437 | 8 437 | |||||
2019-06-06 | 2019-06-05 | 4 | Brege Laura | PCRX | Common Stock | D | 4 134 | 8 761 | ||||||
2019-06-06 | 2019-06-05 | 4 | Froimson Mark | PCRX | Stock Option (Right to Buy) | D | 43,54 | 8 437 | 8 437 | |||||
2019-06-06 | 2019-06-05 | 4 | Froimson Mark | PCRX | Common Stock | D | 4 134 | 5 016 | ||||||
2019-06-06 | 2019-06-05 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 43,54 | 8 437 | 8 437 | |||||
2019-06-06 | 2019-06-05 | 4 | Greenstreet Yvonne | PCRX | Common Stock | D | 4 134 | 9 761 | ||||||
2019-06-06 | 2019-06-05 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 43,54 | 8 437 | 8 437 | |||||
2019-06-06 | 2019-06-05 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 4 134 | 6 881 | ||||||
2019-06-06 | 2019-06-04 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 42,6600 | −782 | −33 | 2 747 | ||||
2019-06-06 | 2019-06-05 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 43,54 | 8 437 | 8 437 | |||||
2019-06-06 | 2019-06-05 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 4 134 | 14 411 | ||||||
2019-06-06 | 2019-06-05 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 43,54 | 30 000 | 30 000 | |||||
2019-06-06 | 2019-06-05 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 5 000 | 10 367 | ||||||
2019-06-06 | 2019-06-04 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 42,9100 | −430 | −18 | 5 367 | ||||
2019-06-05 | 2019-06-03 | 4 | Scranton Richard | PCRX | Stock Option (Right to Buy) | D | 10,81 | −12 500 | 0 | |||||
2019-06-05 | 2019-06-03 | 4 | Scranton Richard | PCRX | Stock Option (Right to Buy) | D | 10,52 | −3 010 | 0 | |||||
2019-06-05 | 2019-06-03 | 4 | Scranton Richard | PCRX | Common Stock | D | 43,2100 | −15 510 | −670 | 20 101 | ||||
2019-06-05 | 2019-06-03 | 4 | Scranton Richard | PCRX | Common Stock | D | 10,8100 | 12 500 | 135 | 35 611 | ||||
2019-06-05 | 2019-06-03 | 4 | Scranton Richard | PCRX | Common Stock | D | 10,5200 | 3 010 | 32 | 23 111 | ||||
2019-03-08 | 2019-03-06 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 39,1400 | 1 000 | 39 | 10 277 | ||||
2019-03-08 | 2019-03-06 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 38,7200 | 700 | 27 | 9 277 | ||||
2018-12-20 | 2018-12-18 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −6 000 | 51 856 | |||||
2018-12-20 | 2018-12-18 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −6 000 | 51 856 | |||||
2018-12-20 | 2018-12-18 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 6 000 | 33 | 133 683 | ||||
2018-12-20 | 2018-12-18 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 6 000 | 10 | 127 683 | ||||
2018-12-14 | 2018-12-13 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 46,1803 | −8 720 | −403 | 950 362 | ||||
2018-12-14 | 2018-12-12 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 47,8394 | −5 807 | −278 | 959 082 | ||||
2018-11-21 | 2018-11-19 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 47,0761 | −990 | −47 | 964 889 | ||||
2018-11-21 | 2018-11-19 | 4 | PACE GARY W | PCRX | Common Stock | D | 46,1800 | 4 500 | 208 | 32 819 | ||||
2018-11-19 | 2018-11-16 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 47,0669 | −3 500 | −165 | 965 879 | ||||
2018-11-19 | 2018-11-16 | 4 | Wicki Andreas See footnote. | PCRX | Common stock | I | 46,7892 | −22 100 | −1 034 | 969 379 | ||||
2018-11-19 | 2018-11-15 | 4 | Wicki Andreas See fotnote. | PCRX | Common Stock | I | 47,6445 | −18 809 | −896 | 991 479 | ||||
2018-11-19 | 2018-11-15 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 47,6318 | −26 089 | −1 243 | 1 010 288 | ||||
2018-11-19 | 2018-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 47,7000 | −4 558 | −217 | 121 683 | ||||
2018-11-19 | 2018-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 47,2500 | −10 442 | −493 | 126 241 | ||||
2018-11-14 | 2018-11-12 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 49,8321 | −5 478 | −273 | 1 036 377 | ||||
2018-11-13 | 2018-11-09 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 50,2298 | −906 | −46 | 1 041 855 | ||||
2018-11-13 | 2018-11-08 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 51,1272 | −57 339 | −2 932 | 1 042 761 | ||||
2018-11-09 | 2018-11-07 | 4 | PACE GARY W | PCRX | Common Stock | D | 51,2900 | 4 000 | 205 | 28 319 | ||||
2018-11-06 | 2018-11-02 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,34 | −1 000 | 23 000 | |||||
2018-11-06 | 2018-11-02 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 54,3500 | −1 000 | −54 | 10 474 | ||||
2018-11-06 | 2018-11-02 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 1 000 | 10 | 11 474 | ||||
2018-10-15 | 2018-10-11 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −15 000 | 57 856 | |||||
2018-10-15 | 2018-10-11 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −18 190 | 65 000 | |||||
2018-10-15 | 2018-10-11 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −11 810 | 0 | |||||
2018-10-15 | 2018-10-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 15 000 | 82 | 136 683 | ||||
2018-10-15 | 2018-10-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 18 190 | 29 | 121 683 | ||||
2018-10-15 | 2018-10-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 11 810 | 19 | 103 493 | ||||
2018-09-26 | 2018-09-24 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,34 | −1 000 | 24 000 | |||||
2018-09-26 | 2018-09-24 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 50,7000 | −1 000 | −51 | 10 474 | ||||
2018-09-26 | 2018-09-24 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 1 000 | 10 | 11 474 | ||||
2018-09-07 | 3 | McLoughlin Dennis | PCRX | Common Stock | D | 29 666 | ||||||||
2018-09-07 | 3 | McLoughlin Dennis | PCRX | Common Stock | D | 29 666 | ||||||||
2018-09-07 | 3 | McLoughlin Dennis | PCRX | Common Stock | D | 29 666 | ||||||||
2018-09-07 | 2018-09-05 | 4 | McLoughlin Dennis | PCRX | Stock Option (Right to Buy) | D | 46,55 | 20 000 | 20 000 | |||||
2018-09-07 | 3 | WINSTON ROY | PCRX | Common Stock | D | 33 000 | ||||||||
2018-09-07 | 3 | WINSTON ROY | PCRX | Common Stock | D | 33 000 | ||||||||
2018-09-07 | 3 | WINSTON ROY | PCRX | Common Stock | D | 33 000 | ||||||||
2018-08-30 | 2018-08-28 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 44,6112 | 1 000 | 45 | 8 577 | ||||
2018-08-24 | 2018-08-22 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 44,4800 | −1 667 | −74 | 10 474 | ||||
2018-08-16 | 2018-08-14 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 47,0400 | −4 773 | −225 | 22 374 | ||||
2018-08-16 | 2018-08-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −13 481 | 0 | |||||
2018-08-16 | 2018-08-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −610 | 0 | |||||
2018-08-16 | 2018-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 47,6900 | −11 864 | −566 | 91 683 | ||||
2018-08-16 | 2018-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 47,1100 | −21 198 | −999 | 103 547 | ||||
2018-08-16 | 2018-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 13 481 | 146 | 124 745 | ||||
2018-08-16 | 2018-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 610 | 3 | 111 264 | ||||
2018-06-15 | 2018-06-13 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 38,35 | 25 000 | 25 000 | |||||
2018-06-15 | 2018-06-13 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 2 500 | 12 141 | ||||||
2018-06-15 | 2018-06-13 | 4 | Scranton Richard | PCRX | Stock Option (Right to Buy) | D | 38,35 | 47 250 | 47 250 | |||||
2018-06-15 | 2018-06-13 | 4 | Scranton Richard | PCRX | Common Stock | D | 7 875 | 20 101 | ||||||
2018-06-15 | 2018-06-13 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 38,35 | 170 250 | 170 250 | |||||
2018-06-15 | 2018-06-13 | 4 | STACK DAVID M | PCRX | Common Stock | D | 28 375 | 110 415 | ||||||
2018-06-15 | 2018-06-13 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 38,35 | 47 250 | 47 250 | |||||
2018-06-15 | 2018-06-13 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 7 875 | 27 147 | ||||||
2018-06-15 | 3 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 476 | ||||||||
2018-06-15 | 3 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 476 | ||||||||
2018-06-15 | 3 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 476 | ||||||||
2018-06-15 | 2018-06-13 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 38,35 | 4 693 | 4 693 | |||||
2018-06-15 | 2018-06-13 | 4 | Brege Laura | PCRX | Common Stock | D | 782 | 4 627 | ||||||
2018-06-15 | 2018-06-13 | 4 | Froimson Mark | PCRX | Stock Option (Right to Buy) | D | 38,35 | 4 693 | 4 693 | |||||
2018-06-15 | 2018-06-13 | 4 | Froimson Mark | PCRX | Common Stock | D | 782 | 882 | ||||||
2018-06-15 | 2018-06-13 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 38,35 | 4 693 | 4 693 | |||||
2018-06-15 | 2018-06-13 | 4 | Greenstreet Yvonne | PCRX | Common Stock | D | 782 | 5 627 | ||||||
2018-06-15 | 2018-06-13 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 38,35 | 4 693 | 4 693 | |||||
2018-06-15 | 2018-06-13 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 782 | 3 529 | ||||||
2018-06-15 | 2018-06-13 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 38,35 | 4 693 | 4 693 | |||||
2018-06-15 | 2018-06-13 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 782 | 7 577 | ||||||
2018-06-15 | 2018-06-13 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 38,35 | 4 693 | 4 693 | |||||
2018-06-15 | 2018-06-13 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 782 | 5 927 | ||||||
2018-06-15 | 2018-06-13 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 38,35 | 4 693 | 4 693 | |||||
2018-06-15 | 2018-06-13 | 4 | PACE GARY W | PCRX | Common Stock | D | 782 | 24 319 | ||||||
2018-06-15 | 2018-06-13 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Stock Option (Right to Buy) | D | 38,35 | 30 000 | 30 000 | |||||
2018-06-15 | 2018-06-13 | 4 | LARANJEIRA CHARLES ANTHONY | PCRX | Common Stock | D | 5 000 | 5 238 | ||||||
2018-06-15 | 2018-06-13 | 4 | Reinhart Charles A. III | PCRX | Stock Option (Right to Buy) | D | 38,35 | 30 000 | 30 000 | |||||
2018-06-15 | 2018-06-13 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 5 000 | 13 042 | ||||||
2018-06-08 | 2018-06-07 | 4 | STACK DAVID M | PCRX | Common Stock | D | 37,5300 | −2 600 | −98 | 82 040 | ||||
2018-06-08 | 2018-06-07 | 4 | STACK DAVID M | PCRX | Common Stock | D | 36,6300 | −7 191 | −263 | 84 640 | ||||
2018-06-08 | 2018-06-06 | 4 | STACK DAVID M | PCRX | Common Stock | D | 35,6100 | −8 615 | −307 | 91 831 | ||||
2018-06-06 | 2018-06-04 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 33,0200 | −2 040 | −67 | 19 272 | ||||
2018-06-06 | 2018-06-04 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 33,9000 | −771 | −26 | 2 747 | ||||
2018-06-06 | 2018-06-04 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 33,0200 | −708 | −23 | 8 042 | ||||
2018-06-06 | 2018-06-04 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 33,0200 | −801 | −26 | 9 641 | ||||
2018-06-06 | 2018-06-04 | 4 | Scranton Richard | PCRX | Common Stock | D | 33,0200 | −1 367 | −45 | 12 226 | ||||
2018-06-06 | 2018-06-04 | 4 | Weiland Robert J. | PCRX | Common Stock | D | 33,0200 | −373 | −12 | 5 088 | ||||
2018-05-17 | 2018-05-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −10 000 | 13 481 | |||||
2018-05-17 | 2018-05-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −15 000 | 610 | |||||
2018-05-17 | 2018-05-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 34,3400 | −3 894 | −134 | 100 446 | ||||
2018-05-17 | 2018-05-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 33,6900 | −21 106 | −711 | 104 340 | ||||
2018-05-17 | 2018-05-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,8100 | 10 000 | 108 | 125 446 | ||||
2018-05-17 | 2018-05-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 15 000 | 82 | 115 446 | ||||
2018-05-04 | 2018-05-02 | 4 | Scranton Richard | PCRX | Stock Option (Right to Buy) | D | 34,38 | 20 000 | 20 000 | |||||
2018-01-12 | 2018-01-10 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −28 885 | 83 190 | |||||
2018-01-12 | 2018-01-10 | 4 | STACK DAVID M | PCRX | Common Stock | D | 41,9700 | −885 | −37 | 100 446 | ||||
2018-01-12 | 2018-01-10 | 4 | STACK DAVID M | PCRX | Common Stock | D | 41,0300 | −4 628 | −190 | 101 331 | ||||
2018-01-12 | 2018-01-10 | 4 | STACK DAVID M | PCRX | Common Stock | D | 39,9600 | −23 372 | −934 | 105 959 | ||||
2018-01-12 | 2018-01-10 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 28 885 | 47 | 129 331 | ||||
2018-01-05 | 2018-01-03 | 4 | Braunstein Scott | PCRX | Stock Option (Right to Buy) | D | 46,35 | 60 000 | 60 000 | |||||
2017-12-18 | 2017-12-15 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 43,7000 | −340 | −15 | 10 442 | ||||
2017-11-20 | 2017-11-20 | 4 | Jones James B | PCRX | Common Stock | D | 41,1088 | −850 | −35 | 16 823 | ||||
2017-11-20 | 2017-11-17 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 25,37 | −7 857 | 0 | |||||
2017-11-20 | 2017-11-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 40,0000 | −7 857 | −314 | 21 312 | ||||
2017-11-20 | 2017-11-17 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 25,3700 | 7 857 | 199 | 29 169 | ||||
2017-11-20 | 2017-11-16 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 25,37 | −2 143 | 7 857 | |||||
2017-11-20 | 2017-11-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 40,0100 | −2 143 | −86 | 21 312 | ||||
2017-11-20 | 2017-11-16 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 25,3700 | 2 143 | 54 | 23 455 | ||||
2017-11-17 | 2017-11-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −28 885 | 112 075 | |||||
2017-11-17 | 2017-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 38,9700 | −1 900 | −74 | 100 279 | ||||
2017-11-17 | 2017-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 38,3200 | −56 985 | −2 184 | 102 179 | ||||
2017-11-17 | 2017-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 28 885 | 47 | 159 164 | ||||
2017-11-13 | 2017-11-10 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 41,6025 | 1 000 | 42 | 6 795 | ||||
2017-08-24 | 2017-08-22 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 36,1500 | −1 044 | −38 | 3 518 | ||||
2017-08-17 | 2017-08-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −28 885 | 11 810 | |||||
2017-08-17 | 2017-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 36,3700 | −28 885 | −1 051 | 130 279 | ||||
2017-08-17 | 2017-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 28 885 | 47 | 159 164 | ||||
2017-08-17 | 2017-08-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 36,7500 | −3 461 | −127 | 21 312 | ||||
2017-08-16 | 2017-08-08 | 4 | Froimson Mark | PCRX | Common Stock | D | 37,1316 | 100 | 4 | 100 | ||||
2017-07-26 | 2017-07-24 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 140 960 | |||||
2017-07-26 | 2017-07-24 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 130 279 | ||||
2017-06-27 | 2017-06-23 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 155 960 | |||||
2017-06-27 | 2017-06-23 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 115 059 | ||||
2017-06-16 | 3 | Scranton Richard | PCRX | Common Stock | D | 9 686 | ||||||||
2017-06-16 | 3 | Scranton Richard | PCRX | Common Stock | D | 9 686 | ||||||||
2017-06-16 | 2017-06-14 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 44,20 | 2 714 | 2 714 | |||||
2017-06-16 | 2017-06-14 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1 357 | 5 145 | ||||||
2017-06-16 | 2017-06-14 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 44,20 | 2 714 | 2 714 | |||||
2017-06-16 | 2017-06-14 | 4 | PACE GARY W | PCRX | Common Stock | D | 1 357 | 23 537 | ||||||
2017-06-16 | 2017-06-14 | 4 | WINGER DENNIS L | PCRX | Stock Option (Right to Buy) | D | 44,20 | 2 714 | 2 714 | |||||
2017-06-16 | 2017-06-14 | 4 | WINGER DENNIS L | PCRX | Common Stock | D | 1 357 | 7 490 | ||||||
2017-06-16 | 2017-06-14 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 44,20 | 2 714 | 2 714 | |||||
2017-06-16 | 2017-06-14 | 4 | Brege Laura | PCRX | Common Stock | D | 1 357 | 3 845 | ||||||
2017-06-16 | 2017-06-14 | 4 | Froimson Mark | PCRX | Stock Option (Right to Buy) | D | 44,20 | 8 144 | 8 144 | |||||
2017-06-16 | 2017-06-14 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 44,20 | 2 714 | 2 714 | |||||
2017-06-16 | 2017-06-14 | 4 | Greenstreet Yvonne | PCRX | Common Stock | D | 1 357 | 4 845 | ||||||
2017-06-16 | 2017-06-14 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 44,20 | 2 714 | 2 714 | |||||
2017-06-16 | 2017-06-14 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 1 357 | 4 562 | ||||||
2017-06-16 | 2017-06-14 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 44,20 | 2 714 | 2 714 | |||||
2017-06-16 | 2017-06-14 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 1 357 | 5 795 | ||||||
2017-06-16 | 2017-06-14 | 4 | Scranton Richard | PCRX | Stock Option (Right to Buy) | D | 44,20 | 17 500 | 17 500 | |||||
2017-06-16 | 2017-06-14 | 4 | Scranton Richard | PCRX | Common Stock | D | 8 750 | 13 593 | ||||||
2017-06-16 | 2017-06-14 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 44,20 | 81 000 | 81 000 | |||||
2017-06-16 | 2017-06-14 | 4 | STACK DAVID M | PCRX | Common Stock | D | 40 500 | 100 059 | ||||||
2017-06-16 | 2017-06-14 | 4 | Weiland Robert J. | PCRX | Stock Option (Right to Buy) | D | 44,20 | 9 000 | 9 000 | |||||
2017-06-16 | 2017-06-14 | 4 | Weiland Robert J. | PCRX | Common Stock | D | 4 500 | 4 864 | ||||||
2017-06-16 | 2017-06-14 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 44,20 | 22 000 | 22 000 | |||||
2017-06-16 | 2017-06-14 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 11 000 | 24 773 | ||||||
2017-06-16 | 2017-06-14 | 4 | Braunstein Scott | PCRX | Stock Option (Right to Buy) | D | 44,20 | 22 000 | 22 000 | |||||
2017-06-16 | 2017-06-14 | 4 | Braunstein Scott | PCRX | Common Stock | D | 11 000 | 20 982 | ||||||
2017-06-16 | 2017-06-02 | 4 | Braunstein Scott | PCRX | Stock Option (Right to Buy) | D | 44,10 | 10 000 | 10 000 | |||||
2017-06-16 | 2017-06-14 | 4 | Jones James B | PCRX | Stock Option (Right to Buy) | D | 44,20 | 15 000 | 15 000 | |||||
2017-06-16 | 2017-06-14 | 4 | Jones James B | PCRX | Common Stock | D | 7 500 | 17 313 | ||||||
2017-06-16 | 2017-06-14 | 4 | Reinhart Charles A. III | PCRX | Stock Option (Right to Buy) | D | 44,20 | 17 500 | 17 500 | |||||
2017-06-16 | 2017-06-14 | 4 | Reinhart Charles A. III | PCRX | Common Stock | D | 8 750 | 8 750 | ||||||
2017-06-16 | 2017-06-14 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 44,20 | 6 000 | 6 000 | |||||
2017-06-16 | 2017-06-14 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 3 000 | 10 063 | ||||||
2017-06-09 | 2017-06-07 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 44,3700 | −1 119 | −50 | 7 063 | ||||
2017-06-07 | 2017-06-05 | 4 | Scibetta James S | PCRX | Common Stock | D | 43,3210 | −1 966 | −85 | 25 118 | ||||
2017-06-07 | 2017-06-05 | 4 | STACK DAVID M | PCRX | Common Stock | D | 43,3210 | −4 311 | −187 | 59 559 | ||||
2017-06-07 | 2017-06-05 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 43,3210 | −1 877 | −81 | 13 773 | ||||
2017-06-07 | 2017-06-05 | 4 | Braunstein Scott | PCRX | Common Stock | D | 43,3210 | −768 | −33 | 9 982 | ||||
2017-06-07 | 2017-06-05 | 4 | Jones James B | PCRX | Common Stock | D | 43,3210 | −767 | −33 | 9 813 | ||||
2017-06-07 | 2017-06-05 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 43,3210 | −601 | −26 | 8 182 | ||||
2017-05-17 | 2017-05-15 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 5,49 | −20 000 | 15 251 | |||||
2017-05-17 | 2017-05-15 | 4 | Scibetta James S | PCRX | Common Stock | D | 51,2000 | −20 000 | −1 024 | 27 084 | ||||
2017-05-17 | 2017-05-15 | 4 | Scibetta James S | PCRX | Common Stock | D | 5,4900 | 20 000 | 110 | 47 084 | ||||
2017-05-17 | 2017-05-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 10,81 | −11 979 | 0 | |||||
2017-05-17 | 2017-05-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 10,52 | −5 937 | 0 | |||||
2017-05-17 | 2017-05-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 9,25 | −3 125 | 0 | |||||
2017-05-17 | 2017-05-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 50,8600 | −21 041 | −1 070 | 15 650 | ||||
2017-05-17 | 2017-05-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 10,8100 | 11 979 | 129 | 36 691 | ||||
2017-05-17 | 2017-05-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 10,5200 | 5 937 | 62 | 24 712 | ||||
2017-05-17 | 2017-05-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 9,2500 | 3 125 | 29 | 18 775 | ||||
2017-01-19 | 2017-01-17 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −15 000 | 15 610 | |||||
2017-01-19 | 2017-01-17 | 4 | STACK DAVID M | PCRX | Common Stock | D | 38,8100 | −1 300 | −50 | 63 870 | ||||
2017-01-19 | 2017-01-17 | 4 | STACK DAVID M | PCRX | Common Stock | D | 38,3700 | −13 700 | −526 | 65 170 | ||||
2017-01-19 | 2017-01-17 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 15 000 | 82 | 78 870 | ||||
2017-01-19 | 2017-01-17 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 5,49 | −17 627 | 35 251 | |||||
2017-01-19 | 2017-01-17 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 1,61 | −2 373 | 0 | |||||
2017-01-19 | 2017-01-17 | 4 | Scibetta James S | PCRX | Common Stock | D | 38,9700 | −4 997 | −195 | 27 084 | ||||
2017-01-19 | 2017-01-17 | 4 | Scibetta James S | PCRX | Common Stock | D | 38,3900 | −15 003 | −576 | 32 081 | ||||
2017-01-19 | 2017-01-17 | 4 | Scibetta James S | PCRX | Common Stock | D | 5,4900 | 17 627 | 97 | 47 084 | ||||
2017-01-19 | 2017-01-17 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 2 373 | 4 | 29 457 | ||||
2016-12-09 | 2016-12-07 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 32,35 | 20 000 | 20 000 | |||||
2016-12-09 | 2016-12-07 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 32,35 | 60 000 | 60 000 | |||||
2016-12-09 | 2016-12-07 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 32,35 | 20 000 | 20 000 | |||||
2016-12-09 | 2016-12-07 | 4 | Reinhart Charles A. III | PCRX | Stock Option (Right to Buy) | D | 32,35 | 16 000 | 16 000 | |||||
2016-12-09 | 2016-12-07 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 32,35 | 6 000 | 6 000 | |||||
2016-12-09 | 2016-12-07 | 4 | Braunstein Scott | PCRX | Stock Option (Right to Buy) | D | 32,35 | 20 000 | 20 000 | |||||
2016-12-09 | 2016-12-07 | 4 | Jones James B | PCRX | Stock Option (Right to Buy) | D | 32,35 | 10 000 | 10 000 | |||||
2016-12-09 | 2016-12-07 | 4 | Weiland Robert J. | PCRX | Stock Option (Right to Buy) | D | 32,35 | 16 000 | 16 000 | |||||
2016-11-17 | 2016-11-15 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 1,61 | −20 000 | 2 373 | |||||
2016-11-17 | 2016-11-15 | 4 | Scibetta James S | PCRX | Common Stock | D | 36,5000 | −20 000 | −730 | 27 084 | ||||
2016-11-17 | 2016-11-15 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 20 000 | 32 | 47 084 | ||||
2016-11-17 | 2016-11-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −15 000 | 30 610 | |||||
2016-11-17 | 2016-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 37,7600 | −1 800 | −68 | 63 637 | ||||
2016-11-17 | 2016-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 37,2100 | −13 200 | −491 | 65 437 | ||||
2016-11-17 | 2016-11-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 15 000 | 82 | 78 637 | ||||
2016-10-07 | 2016-10-05 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −30 000 | 40 695 | |||||
2016-10-07 | 2016-10-05 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 30 000 | 48 | 63 637 | ||||
2016-08-17 | 2016-08-15 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 877 | 22 373 | |||||
2016-08-17 | 2016-08-15 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 1,61 | −9 123 | 0 | |||||
2016-08-17 | 2016-08-15 | 4 | Scibetta James S | PCRX | Common Stock | D | 45,2100 | −25 000 | −1 130 | 27 084 | ||||
2016-08-17 | 2016-08-15 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 15 877 | 26 | 52 084 | ||||
2016-08-17 | 2016-08-15 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 9 123 | 15 | 36 207 | ||||
2016-08-17 | 2016-08-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −15 000 | 45 610 | |||||
2016-08-17 | 2016-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 45,3200 | −15 000 | −680 | 33 637 | ||||
2016-08-17 | 2016-08-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 15 000 | 82 | 48 637 | ||||
2016-06-17 | 2016-06-15 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 40,34 | 2 975 | 2 975 | |||||
2016-06-17 | 2016-06-15 | 4 | Brege Laura | PCRX | Common Stock | D | 1 488 | 2 488 | ||||||
2016-06-17 | 2016-06-15 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 40,34 | 2 975 | 2 975 | |||||
2016-06-17 | 2016-06-15 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 1 488 | 3 205 | ||||||
2016-06-17 | 2016-06-15 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 40,34 | 2 975 | 2 975 | |||||
2016-06-17 | 2016-06-15 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1 488 | 3 788 | ||||||
2016-06-17 | 2016-06-15 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 40,34 | 2 975 | 2 975 | |||||
2016-06-17 | 2016-06-15 | 4 | PACE GARY W | PCRX | Common Stock | D | 1 488 | 22 180 | ||||||
2016-06-17 | 2016-06-15 | 4 | WINGER DENNIS L | PCRX | Stock Option (Right to Buy) | D | 40,34 | 2 975 | 2 975 | |||||
2016-06-17 | 2016-06-15 | 4 | WINGER DENNIS L | PCRX | Common Stock | D | 1 488 | 6 133 | ||||||
2016-06-17 | 2016-06-15 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 40,34 | 32 500 | 32 500 | |||||
2016-06-17 | 2016-06-15 | 4 | Scibetta James S | PCRX | Common Stock | D | 16 250 | 26 754 | ||||||
2016-06-17 | 2016-06-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 40,34 | 66 250 | 66 250 | |||||
2016-06-17 | 2016-06-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 33 125 | 33 410 | ||||||
2016-06-17 | 2016-06-15 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 40,34 | 17 500 | 17 500 | |||||
2016-06-17 | 2016-06-15 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 8 750 | 15 650 | ||||||
2016-06-17 | 2016-06-15 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 40,34 | 2 975 | 2 975 | |||||
2016-06-17 | 2016-06-15 | 4 | Greenstreet Yvonne | PCRX | Common Stock | D | 1 488 | 3 488 | ||||||
2016-06-17 | 2016-06-15 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 40,34 | 6 250 | 6 250 | |||||
2016-06-17 | 2016-06-15 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 3 125 | 8 453 | ||||||
2016-06-17 | 2016-06-15 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 40,34 | 2 975 | 2 975 | |||||
2016-06-17 | 2016-06-15 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 1 488 | 4 438 | ||||||
2016-06-17 | 2016-06-15 | 4 | Braunstein Scott | PCRX | Stock Option (Right to Buy) | D | 40,34 | 17 500 | 17 500 | |||||
2016-06-17 | 2016-06-15 | 4 | Braunstein Scott | PCRX | Common Stock | D | 8 750 | 10 750 | ||||||
2016-06-17 | 2016-06-15 | 4 | Jones James B | PCRX | Stock Option (Right to Buy) | D | 40,34 | 17 500 | 17 500 | |||||
2016-06-17 | 2016-06-15 | 4 | Jones James B | PCRX | Common Stock | D | 8 750 | 10 250 | ||||||
2016-06-17 | 2016-06-15 | 4 | Weiland Robert J. | PCRX | Stock Option (Right to Buy) | D | 40,34 | 10 000 | 10 000 | |||||
2016-06-08 | 2016-06-06 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 46,9500 | −1 136 | −53 | 1 717 | ||||
2016-06-08 | 2016-06-06 | 4 | Brege Laura | PCRX | Common Stock | D | 46,9500 | −1 000 | −47 | 1 000 | ||||
2016-06-08 | 2016-06-06 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 47,1990 | −600 | −28 | 6 900 | ||||
2016-06-08 | 2016-06-07 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 47,9020 | −517 | −25 | 5 328 | ||||
2016-06-08 | 2016-06-07 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 47,8980 | −100 | −5 | 5 845 | ||||
2016-06-08 | 2016-06-06 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 47,1990 | −321 | −15 | 5 945 | ||||
2016-06-08 | 2016-06-06 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 46,9500 | −900 | −42 | 2 950 | ||||
2016-05-04 | 2016-05-03 | 4 | Reinhart Charles A. III | PCRX | Stock Option (Right to Buy) | D | 51,54 | 70 000 | 70 000 | |||||
2016-05-04 | 2016-05-03 | 4 | Weiland Robert J. | PCRX | Stock Option (Right to Buy) | D | 51,54 | 40 000 | 40 000 | |||||
2016-04-19 | 2016-04-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 5,49 | −25 000 | 60 610 | |||||
2016-04-19 | 2016-04-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 64,6200 | −6 350 | −410 | 285 | ||||
2016-04-19 | 2016-04-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 63,9700 | −18 650 | −1 193 | 6 635 | ||||
2016-04-19 | 2016-04-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 5,4900 | 25 000 | 137 | 25 285 | ||||
2016-02-22 | 2016-02-17 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 10,81 | −1 000 | 0 | |||||
2016-02-22 | 2016-02-17 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 13,98 | −2 000 | 3 000 | |||||
2016-02-22 | 2016-02-17 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 60,0000 | −3 000 | −180 | 2 853 | ||||
2016-02-22 | 2016-02-17 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 10,8100 | 1 000 | 11 | 5 853 | ||||
2016-02-22 | 2016-02-17 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 13,9800 | 2 000 | 28 | 4 853 | ||||
2016-02-01 | 2016-01-29 | 4 | Braunstein Scott | PCRX | Common Stock | D | 58,9200 | 2 000 | 118 | 2 000 | ||||
2016-01-29 | 2016-01-27 | 4 | Jones James B | PCRX | Common Stock | D | 62,5000 | 500 | 31 | 1 500 | ||||
2016-01-19 | 2016-01-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 70 695 | |||||
2016-01-19 | 2016-01-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 64,4600 | −4 392 | −283 | 285 | ||||
2016-01-19 | 2016-01-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 63,6900 | −9 608 | −612 | 4 677 | ||||
2016-01-19 | 2016-01-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 62,5500 | −1 000 | −63 | 14 285 | ||||
2016-01-19 | 2016-01-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 15 285 | ||||
2016-01-14 | 2016-01-12 | 4 | Jones James B | PCRX | Common Stock | D | 66,0000 | 1 000 | 66 | 1 000 | ||||
2016-01-14 | 2016-01-12 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 66,5490 | 300 | 20 | 2 300 | ||||
2015-11-24 | 2015-11-20 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 10,81 | −3 000 | 1 000 | |||||
2015-11-24 | 2015-11-20 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 60,0000 | −3 000 | −180 | 2 853 | ||||
2015-11-24 | 2015-11-20 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 10,8100 | 3 000 | 32 | 5 853 | ||||
2015-11-05 | 2015-11-03 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 55,34 | 40 000 | 40 000 | |||||
2015-10-19 | 2015-10-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 85 695 | |||||
2015-10-19 | 2015-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 38,4900 | −600 | −23 | 176 | ||||
2015-10-19 | 2015-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 37,8900 | −7 799 | −296 | 776 | ||||
2015-10-19 | 2015-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 37,1100 | −6 601 | −245 | 8 575 | ||||
2015-10-19 | 2015-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 15 176 | ||||
2015-09-14 | 2015-09-11 | 4 | Scibetta James S | PCRX | Common Stock | D | 61,3700 | 5 000 | 307 | 10 504 | ||||
2015-08-19 | 2015-08-17 | 4 | Jones James B | PCRX | Employee Stock Option (Right to Buy) | D | 61,90 | 40 000 | 40 000 | |||||
2015-08-19 | 2015-08-17 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 10,81 | −3 000 | 4 000 | |||||
2015-08-19 | 2015-08-17 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 60,0200 | −3 000 | −180 | 2 853 | ||||
2015-08-19 | 2015-08-17 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 10,8100 | 3 000 | 32 | 5 853 | ||||
2015-07-17 | 2015-07-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 100 695 | |||||
2015-07-17 | 2015-07-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 67,7800 | −15 000 | −1 017 | 176 | ||||
2015-07-17 | 2015-07-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 15 176 | ||||
2015-07-15 | 2015-07-13 | 4 | Braunstein Scott | PCRX | Employee Stock Option (Right to Buy) | D | 67,11 | 75 000 | 75 000 | |||||
2015-06-05 | 2015-06-03 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 79,43 | 4 000 | 4 000 | |||||
2015-06-05 | 2015-06-03 | 4 | Brege Laura | PCRX | Common Stock | D | 2 000 | 2 000 | ||||||
2015-06-05 | 2015-06-03 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 79,43 | 4 000 | 4 000 | |||||
2015-06-05 | 2015-06-03 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 2 000 | 2 000 | ||||||
2015-06-05 | 2015-06-03 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 79,43 | 4 000 | 4 000 | |||||
2015-06-05 | 2015-06-03 | 4 | PACE GARY W | PCRX | Common Stock | D | 2 000 | 20 692 | ||||||
2015-06-05 | 2015-06-03 | 4 | WINGER DENNIS L | PCRX | Stock Option (Right to Buy) | D | 79,43 | 4 000 | 4 000 | |||||
2015-06-05 | 2015-06-03 | 4 | WINGER DENNIS L | PCRX | Common Stock | D | 2 000 | 4 645 | ||||||
2015-06-05 | 2015-06-03 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 79,43 | 4 000 | 4 000 | |||||
2015-06-05 | 2015-06-03 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 2 000 | 2 853 | ||||||
2015-06-05 | 2015-06-03 | 4 | Williams Kristen Marie | PCRX | Stock Option (Right to Buy) | D | 79,43 | 15 000 | 15 000 | |||||
2015-06-05 | 2015-06-03 | 4 | Williams Kristen Marie | PCRX | Common Stock | D | 7 500 | 7 500 | ||||||
2015-06-05 | 2015-06-03 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 79,43 | 4 000 | 4 000 | |||||
2015-06-05 | 2015-06-03 | 4 | Greenstreet Yvonne | PCRX | Common Stock | D | 2 000 | 2 000 | ||||||
2015-06-05 | 2015-06-03 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 79,43 | 7 500 | 7 500 | |||||
2015-06-05 | 2015-06-03 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 3 750 | 5 980 | ||||||
2015-06-05 | 2015-06-03 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 79,43 | 4 000 | 4 000 | |||||
2015-06-05 | 2015-06-03 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 2 000 | 3 850 | ||||||
2015-04-17 | 2015-04-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −25 000 | 115 695 | |||||
2015-04-17 | 2015-04-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 90,4990 | −25 000 | −2 262 | 59 | ||||
2015-04-17 | 2015-04-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 25 000 | 40 | 25 059 | ||||
2015-04-14 | 2015-04-10 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 13,98 | −2 500 | 5 000 | |||||
2015-04-14 | 2015-04-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 88,0000 | −2 500 | −220 | 853 | ||||
2015-04-14 | 2015-04-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 13,9800 | 2 500 | 35 | 3 353 | ||||
2015-03-19 | 2015-03-17 | 4 | Markvicka Taunia | PCRX | Employee Stock Option (Right to Buy) | D | 5,49 | −8 349 | 0 | |||||
2015-03-19 | 2015-03-17 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 5,4900 | 8 349 | 46 | 8 579 | ||||
2015-03-18 | 2015-03-16 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 10,34 | −5 000 | 25 000 | |||||
2015-03-18 | 2015-03-16 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 95,3400 | −5 000 | −477 | 2 230 | ||||
2015-03-18 | 2015-03-16 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 5 000 | 52 | 7 230 | ||||
2015-03-17 | 2015-03-13 | 4 | PACE GARY W | PCRX | Common Stock | D | 93,8299 | 1 000 | 94 | 18 692 | ||||
2015-03-16 | 2015-03-12 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 29,90 | −3 000 | 0 | |||||
2015-03-16 | 2015-03-12 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 95,2800 | −3 000 | −286 | 0 | ||||
2015-03-16 | 2015-03-12 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 29,9000 | 3 000 | 90 | 3 000 | ||||
2015-02-09 | 2015-02-06 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 38 250 | |||||
2015-02-09 | 2015-02-06 | 4 | Scibetta James S | PCRX | Common Stock | D | 112,9100 | −1 700 | −192 | 5 230 | ||||
2015-02-09 | 2015-02-06 | 4 | Scibetta James S | PCRX | Common Stock | D | 111,9800 | −3 103 | −347 | 6 930 | ||||
2015-02-09 | 2015-02-06 | 4 | Scibetta James S | PCRX | Common Stock | D | 111,1100 | −5 904 | −656 | 10 033 | ||||
2015-02-09 | 2015-02-06 | 4 | Scibetta James S | PCRX | Common Stock | D | 110,1700 | −4 293 | −473 | 15 937 | ||||
2015-02-09 | 2015-02-06 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 20 230 | ||||
2015-01-20 | 2015-01-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 140 695 | |||||
2015-01-20 | 2015-01-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 98,7400 | −1 600 | −158 | 1 267 | ||||
2015-01-20 | 2015-01-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 97,7100 | −2 500 | −244 | 2 867 | ||||
2015-01-20 | 2015-01-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 97,3000 | −10 900 | −1 061 | 5 367 | ||||
2015-01-20 | 2015-01-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 16 267 | ||||
2015-01-14 | 2015-01-12 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 13,98 | −2 500 | 7 500 | |||||
2015-01-14 | 2015-01-12 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 94,0600 | −2 500 | −235 | 853 | ||||
2015-01-14 | 2015-01-12 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 13,9800 | 2 500 | 35 | 3 353 | ||||
2014-12-30 | 2014-12-29 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 29,90 | −1 000 | 3 000 | |||||
2014-12-30 | 2014-12-29 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 93,3200 | −1 000 | −93 | 0 | ||||
2014-12-30 | 2014-12-29 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 29,9000 | 1 000 | 30 | 1 000 | ||||
2014-12-08 | 2014-12-05 | 4 | WINGER DENNIS L | PCRX | Common Stock | D | 94,5400 | 2 645 | 250 | 2 645 | ||||
2014-11-12 | 2014-11-07 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 53 250 | |||||
2014-11-12 | 2014-11-07 | 4 | Scibetta James S | PCRX | Common Stock | D | 90,3300 | −200 | −18 | 5 000 | ||||
2014-11-12 | 2014-11-07 | 4 | Scibetta James S | PCRX | Common Stock | D | 89,5600 | −800 | −72 | 5 200 | ||||
2014-11-12 | 2014-11-07 | 4 | Scibetta James S | PCRX | Common Stock | D | 87,6500 | −3 100 | −272 | 6 000 | ||||
2014-11-12 | 2014-11-07 | 4 | Scibetta James S | PCRX | Common Stock | D | 86,9900 | −8 600 | −748 | 9 100 | ||||
2014-11-12 | 2014-11-07 | 4 | Scibetta James S | PCRX | Common Stock | D | 86,1300 | −2 300 | −198 | 17 700 | ||||
2014-11-12 | 2014-11-07 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 20 000 | ||||
2014-11-12 | 2014-11-07 | 4 | Markvicka Taunia By spouse | PCRX | Common Stock | I | 86,6200 | 230 | 20 | 230 | ||||
2014-11-04 | 2014-11-03 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 90,4800 | 850 | 77 | 1 850 | ||||
2014-10-17 | 2014-10-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 170 960 | |||||
2014-10-17 | 2014-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 101,2000 | −1 198 | −121 | 1 208 | ||||
2014-10-17 | 2014-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 99,8000 | −7 485 | −747 | 2 406 | ||||
2014-10-17 | 2014-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 99,0500 | −5 417 | −537 | 9 891 | ||||
2014-10-17 | 2014-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 97,7400 | −600 | −59 | 15 308 | ||||
2014-10-17 | 2014-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 96,6000 | −300 | −29 | 15 908 | ||||
2014-10-17 | 2014-10-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 16 208 | ||||
2014-10-17 | 2014-09-09 | 4 | STACK DAVID M LCK Investments LLC | PCRX | Stock Option (Right to Buy) | I | 81,00 | 150 000 | 150 000 | |||||
2014-10-17 | 2014-09-09 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 81,00 | −150 000 | 0 | |||||
2014-10-17 | 2014-09-09 | 4 | STACK DAVID M LCK Investments LLC | PCRX | Stock Option (Right to Buy) | I | 10,81 | 350 000 | 350 000 | |||||
2014-10-17 | 2014-09-09 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 10,81 | −350 000 | 0 | |||||
2014-10-14 | 2014-10-10 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 13,98 | −2 500 | 10 000 | |||||
2014-10-14 | 2014-10-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 94,8700 | −2 500 | −237 | 853 | ||||
2014-10-14 | 2014-10-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 13,9800 | 2 500 | 35 | 3 353 | ||||
2014-09-30 | 2014-09-29 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 29,90 | −1 000 | 4 000 | |||||
2014-09-30 | 2014-09-29 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 96,4000 | −1 000 | −96 | 0 | ||||
2014-09-30 | 2014-09-29 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 29,9000 | 1 000 | 30 | 1 000 | ||||
2014-09-02 | 2014-08-29 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 108,1538 | −10 481 | −1 134 | 1 100 100 | ||||
2014-09-02 | 2014-08-28 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 108,0629 | −11 013 | −1 190 | 1 110 581 | ||||
2014-08-27 | 2014-08-27 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 108,0539 | −1 606 | −174 | 1 121 594 | ||||
2014-08-27 | 2014-08-26 | 4 | Wicki Andreas | PCRX | Common Stock | I | 108,1099 | −24 207 | −2 617 | 1 123 200 | ||||
2014-08-27 | 2014-08-25 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 108,0661 | −30 000 | −3 242 | 1 147 407 | ||||
2014-08-12 | 2014-08-11 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 101,8232 | −37 786 | −3 847 | 1 177 407 | ||||
2014-08-12 | 2014-08-11 | 4 | Wicki Andreas | PCRX | Common Stock | I | 101,1959 | −30 114 | −3 047 | 1 215 193 | ||||
2014-08-12 | 2014-08-08 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 101,0001 | −82 100 | −8 292 | 1 245 307 | ||||
2014-08-11 | 2014-08-08 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 1,61 | −6 134 | 68 250 | |||||
2014-08-11 | 2014-08-08 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 1,61 | −8 866 | 9 123 | |||||
2014-08-11 | 2014-08-08 | 4 | Scibetta James S | PCRX | Common Stock | D | 99,8300 | −10 000 | −998 | 5 000 | ||||
2014-08-11 | 2014-08-08 | 4 | Scibetta James S | PCRX | Common Stock | D | 99,2200 | −5 000 | −496 | 15 000 | ||||
2014-08-11 | 2014-08-08 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 6 134 | 10 | 20 000 | ||||
2014-08-11 | 2014-08-08 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 8 866 | 14 | 13 866 | ||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 11,68 | −3 524 | 56 476 | |||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 10,81 | −14 364 | 18 333 | |||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 5,49 | −882 | 4 414 | |||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | −1 230 | 1 230 | |||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Common Stock | D | 100,2600 | −20 000 | −2 005 | 0 | ||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Common Stock | D | 11,6800 | 3 524 | 41 | 20 000 | ||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Common Stock | D | 10,8100 | 14 364 | 155 | 16 476 | ||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Common Stock | D | 5,4900 | 882 | 5 | 2 112 | ||||
2014-08-08 | 2014-08-07 | 4 | PATOU GARY | PCRX | Common Stock | D | 1,6100 | 1 230 | 2 | 1 230 | ||||
2014-07-16 | 2014-07-15 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 1,61 | −15 000 | 155 695 | |||||
2014-07-16 | 2014-07-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 88,2300 | −1 000 | −88 | 1 208 | ||||
2014-07-16 | 2014-07-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 87,0500 | −6 600 | −575 | 2 208 | ||||
2014-07-16 | 2014-07-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 86,2800 | −7 400 | −638 | 8 808 | ||||
2014-07-16 | 2014-07-15 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 16 208 | ||||
2014-07-15 | 2014-07-14 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 10,81 | −7 303 | 32 697 | |||||
2014-07-15 | 2014-07-14 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 5,49 | −20 237 | 5 296 | |||||
2014-07-15 | 2014-07-14 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | −2 460 | 2 460 | |||||
2014-07-15 | 2014-07-14 | 4 | PATOU GARY | PCRX | Common Stock | D | 87,5800 | −2 107 | −185 | 0 | ||||
2014-07-15 | 2014-07-14 | 4 | PATOU GARY | PCRX | Common Stock | D | 86,9100 | −27 593 | −2 398 | 2 407 | ||||
2014-07-15 | 2014-07-14 | 4 | PATOU GARY | PCRX | Common Stock | D | 10,8100 | 7 303 | 79 | 30 000 | ||||
2014-07-15 | 2014-07-14 | 4 | PATOU GARY | PCRX | Common Stock | D | 5,4900 | 20 237 | 111 | 22 697 | ||||
2014-07-15 | 2014-07-14 | 4 | PATOU GARY | PCRX | Common Stock | D | 1,6100 | 2 460 | 4 | 2 460 | ||||
2014-07-11 | 2014-07-10 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 13,98 | −2 500 | 12 500 | |||||
2014-07-11 | 2014-07-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 85,9600 | −698 | −60 | 853 | ||||
2014-07-11 | 2014-07-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 85,0300 | −502 | −43 | 1 551 | ||||
2014-07-11 | 2014-07-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 84,0800 | −700 | −59 | 2 053 | ||||
2014-07-11 | 2014-07-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 82,4600 | −600 | −49 | 2 753 | ||||
2014-07-11 | 2014-07-10 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 13,9800 | 2 500 | 35 | 3 353 | ||||
2014-07-02 | 2014-06-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 29,90 | −1 000 | 5 000 | |||||
2014-07-02 | 2014-06-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 91,6000 | −1 000 | −92 | 0 | ||||
2014-07-02 | 2014-06-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 29,9000 | 1 000 | 30 | 1 000 | ||||
2014-06-11 | 2014-06-09 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 86,4336 | −9 289 | −803 | 1 327 407 | ||||
2014-06-11 | 2014-06-09 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 85,8075 | −33 653 | −2 888 | 1 336 696 | ||||
2014-06-11 | 2014-06-09 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 84,5488 | −25 058 | −2 119 | 1 370 349 | ||||
2014-06-06 | 2014-06-06 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 82,7053 | −40 200 | −3 325 | 1 395 407 | ||||
2014-06-06 | 2014-06-05 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 82,5288 | −23 200 | −1 915 | 1 435 607 | ||||
2014-06-06 | 2014-06-04 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 82,4019 | −4 500 | −371 | 1 458 807 | ||||
2014-06-05 | 2014-06-03 | 4 | STACK DAVID M | PCRX | Stock Option (Right to Buy) | D | 81,00 | 150 000 | 150 000 | |||||
2014-06-05 | 2014-06-03 | 4 | Scibetta James S | PCRX | Stock Option (Right to Buy) | D | 81,00 | 70 000 | 70 000 | |||||
2014-06-05 | 2014-06-03 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 81,00 | 8 000 | 8 000 | |||||
2014-06-05 | 2014-06-03 | 4 | WINGER DENNIS L | PCRX | Stock Option (Right to Buy) | D | 81,00 | 8 000 | 8 000 | |||||
2014-06-05 | 2014-06-03 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 81,00 | 8 000 | 8 000 | |||||
2014-06-05 | 2014-06-03 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 81,00 | 8 000 | 8 000 | |||||
2014-06-05 | 2014-06-03 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 81,00 | 8 000 | 8 000 | |||||
2014-06-05 | 2014-06-03 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 81,00 | 25 000 | 25 000 | |||||
2014-06-05 | 2014-06-03 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 81,00 | 8 000 | 8 000 | |||||
2014-06-05 | 2014-06-03 | 4 | Markvicka Taunia | PCRX | Stock Option (Right to Buy) | D | 81,00 | 70 000 | 70 000 | |||||
2014-06-05 | 2014-06-03 | 4 | Riker Lauren Bullaro | PCRX | Stock Option (Right to Buy) | D | 81,00 | 15 000 | 15 000 | |||||
2014-06-05 | 2014-06-03 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 81,00 | 8 000 | 8 000 | |||||
2014-06-03 | 2014-06-03 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 80,7179 | −57 400 | −4 633 | 1 463 307 | ||||
2014-06-03 | 2014-06-02 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 80,5187 | −10 600 | −853 | 1 520 707 | ||||
2014-05-28 | 2014-05-27 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 77,9309 | −64 400 | −5 019 | 1 531 307 | ||||
2014-05-22 | 2014-05-21 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 77,8017 | −3 600 | −280 | 1 595 707 | ||||
2014-05-13 | 2014-05-12 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 5,49 | −10 000 | 25 532 | |||||
2014-05-13 | 2014-05-12 | 4 | PATOU GARY | PCRX | Common Stock | D | 75,0000 | −10 000 | −750 | 0 | ||||
2014-05-13 | 2014-05-12 | 4 | PATOU GARY | PCRX | Common Stock | D | 5,4900 | 10 000 | 55 | 10 000 | ||||
2014-05-13 | 2014-05-09 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 5,49 | −6 836 | 35 532 | |||||
2014-05-13 | 2014-05-09 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | −13 164 | 4 920 | |||||
2014-05-13 | 2014-05-09 | 4 | PATOU GARY | PCRX | Common Stock | D | 74,0800 | −20 000 | −1 482 | 0 | ||||
2014-05-13 | 2014-05-09 | 4 | PATOU GARY | PCRX | Common Stock | D | 5,4900 | 6 836 | 38 | 20 000 | ||||
2014-05-13 | 2014-05-09 | 4 | PATOU GARY | PCRX | Common Stock | D | 1,6100 | 13 164 | 21 | 13 164 | ||||
2014-05-12 | 2014-05-08 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 75,7629 | −23 220 | −1 759 | 1 599 307 | ||||
2014-05-09 | 2014-05-08 | 4 | Scibetta James S | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −15 000 | 17 989 | |||||
2014-05-09 | 2014-05-08 | 4 | Scibetta James S | PCRX | Common Stock | D | 75,8000 | −300 | −23 | 5 000 | ||||
2014-05-09 | 2014-05-08 | 4 | Scibetta James S | PCRX | Common Stock | D | 75,2500 | −11 400 | −858 | 5 300 | ||||
2014-05-09 | 2014-05-08 | 4 | Scibetta James S | PCRX | Common Stock | D | 74,2700 | −3 300 | −245 | 16 700 | ||||
2014-05-09 | 2014-05-08 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 20 000 | ||||
2014-05-09 | 2014-05-09 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 13,98 | −3 000 | 12 000 | |||||
2014-05-09 | 2014-05-09 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 10,81 | −7 000 | 0 | |||||
2014-05-09 | 2014-05-09 | 4 | Brege Laura | PCRX | Common Stock | D | 74,6700 | −2 500 | −187 | 0 | ||||
2014-05-09 | 2014-05-09 | 4 | Brege Laura | PCRX | Common Stock | D | 73,5700 | −7 500 | −552 | 2 500 | ||||
2014-05-09 | 2014-05-09 | 4 | Brege Laura | PCRX | Common Stock | D | 13,9800 | 3 000 | 42 | 10 000 | ||||
2014-05-09 | 2014-05-09 | 4 | Brege Laura | PCRX | Common Stock | D | 10,8100 | 7 000 | 76 | 7 000 | ||||
2014-05-09 | 2014-05-09 | 4 | STACK DAVID M | PCRX | Employee Stock Option (Right to Buy) | D | 1,61 | −25 000 | 170 695 | |||||
2014-05-09 | 2014-05-09 | 4 | STACK DAVID M | PCRX | Common Stock | D | 74,8000 | −300 | −22 | 1 208 | ||||
2014-05-09 | 2014-05-09 | 4 | STACK DAVID M | PCRX | Common Stock | D | 74,1500 | −17 300 | −1 283 | 1 508 | ||||
2014-05-09 | 2014-05-09 | 4 | STACK DAVID M | PCRX | Common Stock | D | 73,4000 | −7 400 | −543 | 18 808 | ||||
2014-05-09 | 2014-05-09 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 25 000 | 40 | 26 208 | ||||
2014-05-07 | 2014-05-07 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 75,6425 | −600 | −45 | 1 622 527 | ||||
2014-05-07 | 2014-05-06 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 75,7823 | −44 180 | −3 348 | 1 623 127 | ||||
2014-03-31 | 2014-03-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (right to buy) | D | 29,90 | −1 000 | 6 000 | |||||
2014-03-31 | 2014-03-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 64,6300 | −1 000 | −65 | 0 | ||||
2014-03-31 | 2014-03-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 29,9000 | 1 000 | 30 | 1 000 | ||||
2014-03-13 | 2014-03-11 | 4 | STACK DAVID M | PCRX | Common Stock | D | 221 | 1 208 | ||||||
2014-03-12 | 2014-03-11 | 4 | PATOU GARY | PCRX | Common Stock | I | 504 | 702 | ||||||
2014-03-06 | 2014-03-04 | 4 | Greenstreet Yvonne | PCRX | Stock Option (Right to Buy) | D | 80,43 | 15 000 | 15 000 | |||||
2014-03-06 | 2014-03-06 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 80,1111 | −2 200 | −176 | 1 667 307 | ||||
2014-03-06 | 2014-03-05 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 80,1627 | −22 687 | −1 819 | 1 669 507 | ||||
2014-02-07 | 2013-04-16 | 5 | STACK DAVID M | PCRX | Common Stock | D | −2 000 | 987 | ||||||
2014-01-02 | 2013-12-30 | 4 | Scibetta James S | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −10 000 | 32 989 | |||||
2014-01-02 | 2013-12-30 | 4 | Scibetta James S | PCRX | Common Stock | D | 55,5500 | −10 000 | −556 | 5 000 | ||||
2014-01-02 | 2013-12-30 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 10 000 | 16 | 15 000 | ||||
2014-01-02 | 2013-12-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (right to buy) | D | 1,61 | −574 | 6 864 | |||||
2014-01-02 | 2013-12-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (right to buy) | D | 1,61 | −1 345 | 0 | |||||
2014-01-02 | 2013-12-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (right to buy) | D | 1,61 | −581 | 872 | |||||
2014-01-02 | 2013-12-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 55,5500 | −2 500 | −139 | 0 | ||||
2014-01-02 | 2013-12-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 574 | 1 | 2 500 | ||||
2014-01-02 | 2013-12-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 1 345 | 2 | 1 926 | ||||
2014-01-02 | 2013-12-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 581 | 1 | 581 | ||||
2014-01-02 | 2013-12-30 | 4 | STACK DAVID M | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −15 000 | 195 695 | |||||
2014-01-02 | 2013-12-30 | 4 | STACK DAVID M | PCRX | Common Stock | D | 55,8373 | −15 000 | −838 | 2 987 | ||||
2014-01-02 | 2013-12-30 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 17 987 | ||||
2013-11-20 | 2013-11-18 | 4 | STACK DAVID M | PCRX | Common Stock | D | 414 | 2 987 | ||||||
2013-11-19 | 2013-11-18 | 4 | PATOU GARY | PCRX | Common Stock | I | 83 | 198 | ||||||
2013-11-08 | 2013-11-06 | 4 | Markvicka Taunia | PCRX | Employee Stock Option (right to buy) | D | 10,81 | −50 000 | 100 000 | |||||
2013-11-08 | 2013-11-06 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 53,6130 | −1 802 | −97 | 0 | ||||
2013-11-08 | 2013-11-06 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 52,4940 | −5 681 | −298 | 1 802 | ||||
2013-11-08 | 2013-11-06 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 51,3560 | −14 123 | −725 | 7 483 | ||||
2013-11-08 | 2013-11-06 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 50,6040 | −28 394 | −1 437 | 21 606 | ||||
2013-11-08 | 2013-11-06 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 10,8100 | 50 000 | 540 | 50 000 | ||||
2013-10-04 | 2013-10-01 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | −20 000 | 18 084 | |||||
2013-10-04 | 2013-10-01 | 4 | PATOU GARY | PCRX | Common Stock | D | 48,9200 | −20 000 | −978 | 0 | ||||
2013-10-04 | 2013-10-01 | 4 | PATOU GARY | PCRX | Common Stock | D | 1,6100 | 20 000 | 32 | 20 000 | ||||
2013-10-02 | 2013-09-30 | 4 | STACK DAVID M | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −15 000 | 210 695 | |||||
2013-10-02 | 2013-09-30 | 4 | STACK DAVID M | PCRX | Common Stock | D | 47,5500 | −1 094 | −52 | 2 573 | ||||
2013-10-02 | 2013-09-30 | 4 | STACK DAVID M | PCRX | Common Stock | D | 47,0100 | −13 906 | −654 | 3 667 | ||||
2013-10-02 | 2013-09-30 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 17 573 | ||||
2013-10-02 | 2013-09-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (right to buy) | D | 1,61 | −2 500 | 1 345 | |||||
2013-10-02 | 2013-09-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 46,7400 | −2 500 | −117 | 0 | ||||
2013-10-02 | 2013-09-30 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 2 500 | 4 | 2 500 | ||||
2013-10-02 | 2013-09-30 | 4 | Scibetta James S | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −10 000 | 42 989 | |||||
2013-10-02 | 2013-09-30 | 4 | Scibetta James S | PCRX | Common Stock | D | 46,7400 | −10 000 | −467 | 5 000 | ||||
2013-10-02 | 2013-09-30 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 10 000 | 16 | 15 000 | ||||
2013-09-27 | 2013-09-25 | 4 | Markvicka Taunia | PCRX | Employee Stock Option (right to buy) | D | 5,49 | −10 000 | 8 349 | |||||
2013-09-27 | 2013-09-25 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 47,0000 | −10 000 | −470 | 0 | ||||
2013-09-27 | 2013-09-25 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 5,4900 | 10 000 | 55 | 10 000 | ||||
2013-09-13 | 2013-09-11 | 4 | WINGER DENNIS L | PCRX | Stock Option (Right to Buy) | D | 37,11 | 15 000 | 15 000 | |||||
2013-09-13 | 2013-09-11 | 4 | Kronenfeld Mark A. | PCRX | Common Stock | D | 37,0100 | 1 000 | 37 | 1 000 | ||||
2013-09-12 | 2013-09-11 | 4 | Wicki Andreas See footnote. | PCRX | Warrant (right to buy) | I | 13,44 | −41 841 | 0 | |||||
2013-09-12 | 2013-09-11 | 4 | Wicki Andreas See footnote. | PCRX | Warrant (right to buy) | I | 2,69 | −37 192 | 0 | |||||
2013-09-12 | 2013-09-11 | 4 | Wicki Andreas See foootnote. | PCRX | Common Stock | I | 37,2500 | −15 097 | −562 | 1 692 194 | ||||
2013-09-12 | 2013-09-11 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 13,4400 | 41 841 | 562 | 1 707 291 | ||||
2013-09-12 | 2013-09-11 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 37,2500 | −2 686 | −100 | 1 665 450 | ||||
2013-09-12 | 2013-09-11 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 2,6900 | 37 192 | 100 | 1 668 136 | ||||
2013-08-16 | 2013-08-14 | 4 | Markvicka Taunia | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −14 700 | 6 685 | |||||
2013-08-16 | 2013-08-14 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 37,0000 | −14 700 | −544 | 0 | ||||
2013-08-16 | 2013-08-14 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 1,6100 | 14 700 | 24 | 14 700 | ||||
2013-07-23 | 2013-07-22 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 35,2848 | −19 938 | −704 | 1 630 944 | ||||
2013-07-23 | 2013-07-19 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 34,9790 | −56 020 | −1 960 | 1 650 882 | ||||
2013-07-19 | 2013-07-18 | 4 | Wicki Andreas | PCRX | Common Stock | I | 34,8000 | −4 042 | −141 | 1 706 902 | ||||
2013-07-19 | 2013-07-17 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 33,2000 | −21 518 | −714 | 1 710 944 | ||||
2013-07-17 | 2013-07-16 | 4 | Wicki Andreas | PCRX | Common Stock | I | 33,2000 | −350 | −12 | 1 732 462 | ||||
2013-07-17 | 2013-07-15 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 33,2800 | −48 132 | −1 602 | 1 732 812 | ||||
2013-07-15 | 2013-07-11 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 31,4802 | −80 000 | −2 518 | 1 780 944 | ||||
2013-07-15 | 2013-07-12 | 4 | Markvicka Taunia | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −29 754 | 0 | |||||
2013-07-15 | 2013-07-12 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 32,0000 | −29 754 | −952 | 0 | ||||
2013-07-15 | 2013-07-12 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 1,6100 | 29 754 | 48 | 29 754 | ||||
2013-07-09 | 2013-07-05 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,8026 | −44 021 | −1 356 | 1 860 944 | ||||
2013-07-03 | 2013-07-03 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,6660 | −50 000 | −1 533 | 1 904 965 | ||||
2013-07-03 | 2013-07-02 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 29,8500 | −60 597 | −1 809 | 1 954 965 | ||||
2013-07-03 | 2013-07-01 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 29,8500 | −3 851 | −115 | 2 015 562 | ||||
2013-07-02 | 2013-06-28 | 4 | STACK DAVID M | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −15 000 | 225 695 | |||||
2013-07-02 | 2013-06-28 | 4 | STACK DAVID M | PCRX | Common Stock | D | 28,7311 | −15 000 | −431 | 2 573 | ||||
2013-07-02 | 2013-06-28 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 17 573 | ||||
2013-07-02 | 2013-06-28 | 4 | Scibetta James S | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −10 000 | 52 989 | |||||
2013-07-02 | 2013-06-28 | 4 | Scibetta James S | PCRX | Common Stock | D | 28,0460 | −10 000 | −280 | 5 000 | ||||
2013-07-02 | 2013-06-28 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 10 000 | 16 | 15 000 | ||||
2013-07-02 | 2013-06-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (right to buy) | D | 1,61 | −804 | 3 845 | |||||
2013-07-02 | 2013-06-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (right to buy) | D | 1,61 | −1 196 | 1 453 | |||||
2013-07-02 | 2013-06-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 28,0892 | −2 000 | −56 | 0 | ||||
2013-07-02 | 2013-06-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 804 | 1 | 2 000 | ||||
2013-07-02 | 2013-06-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 1 196 | 2 | 1 196 | ||||
2013-07-02 | 2013-07-02 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | −10 000 | 38 084 | |||||
2013-07-02 | 2013-07-02 | 4 | PATOU GARY | PCRX | Common Stock | D | 30,0000 | −10 000 | −300 | 0 | ||||
2013-07-02 | 2013-07-02 | 4 | PATOU GARY | PCRX | Common Stock | D | 1,6100 | 10 000 | 16 | 10 000 | ||||
2013-07-02 | 2013-07-01 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | −10 958 | 48 084 | |||||
2013-07-02 | 2013-07-01 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | −19 042 | 0 | |||||
2013-07-02 | 2013-07-01 | 4 | PATOU GARY | PCRX | Common Stock | D | 29,2500 | −30 000 | −878 | 0 | ||||
2013-07-02 | 2013-07-01 | 4 | PATOU GARY | PCRX | Common Stock | D | 1,6100 | 30 000 | 48 | 30 000 | ||||
2013-06-25 | 2013-06-24 | 4 | MIDDLETON FRED A | PCRX | Common Stock | I | 28,7000 | −5 900 | −169 | 0 | ||||
2013-06-25 | 2013-06-21 | 4 | MIDDLETON FRED A | PCRX | Common Stock | I | 28,4900 | −2 828 | −81 | 5 900 | ||||
2013-06-25 | 2013-06-21 | 4 | MIDDLETON FRED A | PCRX | Common Stock | I | 29,2200 | −36 374 | −1 063 | 8 728 | ||||
2013-06-25 | 2013-06-21 | 4 | MIDDLETON FRED A | PCRX | Common Stock | I | 28,4900 | −2 222 | −63 | 0 | ||||
2013-06-25 | 2013-06-21 | 4 | MIDDLETON FRED A | PCRX | Common Stock | I | 29,2200 | −28 576 | −835 | 2 222 | ||||
2013-06-21 | 2013-06-19 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 29,9016 | −35 407 | −1 059 | 2 019 413 | ||||
2013-06-20 | 2013-06-20 | 4 | MIDDLETON FRED A See footnotes | PCRX | Common Stock | I | 28,9300 | −66 100 | −1 912 | 30 798 | ||||
2013-06-20 | 2013-06-19 | 4 | MIDDLETON FRED A See footnotes | PCRX | Common Stock | I | 29,7600 | −48 400 | −1 440 | 96 898 | ||||
2013-06-20 | 2013-06-18 | 4 | MIDDLETON FRED A See footnotes | PCRX | Common Stock | I | 29,4800 | −29 600 | −873 | 145 298 | ||||
2013-06-19 | 2013-06-17 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 29,8579 | −50 145 | −1 497 | 2 054 820 | ||||
2013-06-14 | 2013-06-12 | 4 | MIDDLETON FRED A | PCRX | Stock Option (Right to Buy) | D | 29,20 | 7 000 | 7 000 | |||||
2013-06-14 | 2013-06-12 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (Right to Buy) | D | 29,20 | 7 000 | 7 000 | |||||
2013-06-14 | 2013-06-12 | 4 | PACE GARY W | PCRX | Stock Option (Right to Buy) | D | 29,20 | 7 000 | 7 000 | |||||
2013-06-14 | 2013-06-12 | 4 | HASTINGS PAUL J | PCRX | Stock Option (Right to Buy) | D | 29,20 | 7 000 | 7 000 | |||||
2013-06-14 | 2013-06-12 | 4 | Brege Laura | PCRX | Stock Option (Right to Buy) | D | 29,20 | 7 000 | 7 000 | |||||
2013-06-14 | 2013-06-12 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −4 409 | −132 | 2 104 965 | ||||
2013-06-14 | 2013-06-13 | 4 | Pratt John | PCRX | Employee Stock Option (right to buy) | D | 8,73 | −1 875 | 18 750 | |||||
2013-06-14 | 2013-06-13 | 4 | Pratt John | PCRX | Employee Stock Option (right to buy) | D | 10,81 | −18 232 | 112 500 | |||||
2013-06-14 | 2013-06-13 | 4 | Pratt John | PCRX | Common Stock | D | 30,0000 | −1 875 | −56 | 0 | ||||
2013-06-14 | 2013-06-13 | 4 | Pratt John | PCRX | Common Stock | D | 8,7300 | 1 875 | 16 | 1 875 | ||||
2013-06-14 | 2013-06-13 | 4 | Pratt John | PCRX | Common Stock | D | 30,0000 | −18 232 | −547 | 0 | ||||
2013-06-14 | 2013-06-13 | 4 | Pratt John | PCRX | Common Stock | D | 10,8100 | 18 232 | 197 | 18 232 | ||||
2013-06-14 | 2013-06-12 | 4 | Pratt John | PCRX | Employee Stock Option (right to buy) | D | 10,81 | −925 | 130 732 | |||||
2013-06-14 | 2013-06-12 | 4 | Pratt John | PCRX | Common Stock | D | 30,0000 | −925 | −28 | 0 | ||||
2013-06-14 | 2013-06-12 | 4 | Pratt John | PCRX | Common Stock | D | 10,8100 | 925 | 10 | 925 | ||||
2013-06-14 | 2013-06-12 | 4 | Kronenfeld Mark A. | PCRX | Stock Option (Right to Buy) | D | 29,20 | 15 000 | 15 000 | |||||
2013-06-13 | 2013-06-13 | 4 | EVNIN LUKE | PCRX | Common Stock | D | 30,0745 | −20 311 | −611 | 0 | ||||
2013-06-13 | 2013-06-12 | 4 | EVNIN LUKE | PCRX | Director Stock Option (Right to Buy) | D | 29,90 | 7 000 | 7 000 | |||||
2013-06-13 | 2013-06-12 | 4 | EVNIN LUKE | PCRX | Common Stock | D | 30,0000 | −2 435 | −73 | 20 311 | ||||
2013-06-12 | 2013-06-11 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −9 000 | −270 | 2 109 374 | ||||
2013-06-12 | 2013-06-10 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −2 500 | −75 | 2 118 374 | ||||
2013-06-12 | 2013-06-11 | 4 | Pratt John | PCRX | Employee Stock Option (right to buy) | D | 10,81 | −12 945 | 131 657 | |||||
2013-06-12 | 2013-06-11 | 4 | Pratt John | PCRX | Common Stock | D | 30,0000 | −12 945 | −388 | 0 | ||||
2013-06-12 | 2013-06-11 | 4 | Pratt John | PCRX | Common Stock | D | 10,8100 | 12 945 | 140 | 12 945 | ||||
2013-06-12 | 2013-06-10 | 4 | Pratt John | PCRX | Employee Stock Option (right to buy) | D | 10,81 | −5 398 | 144 602 | |||||
2013-06-12 | 2013-06-10 | 4 | Pratt John | PCRX | Common Stock | D | 30,0000 | −5 398 | −162 | 0 | ||||
2013-06-12 | 2013-06-10 | 4 | Pratt John | PCRX | Common Stock | D | 10,8100 | 5 398 | 58 | 5 398 | ||||
2013-06-07 | 2013-06-05 | 4 | MIDDLETON FRED A | PCRX | Common Stock | D | 7 433 | 70 399 | ||||||
2013-06-07 | 2013-06-05 | 4 | MIDDLETON FRED A See Footnotes | PCRX | Common Stock | I | −241 185 | 174 898 | ||||||
2013-06-07 | 2013-06-05 | 4 | MIDDLETON FRED A See Footnotes | PCRX | Common Stock | I | −316 660 | 45 102 | ||||||
2013-06-06 | 2013-06-05 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −2 500 | −75 | 2 120 874 | ||||
2013-06-06 | 2013-06-04 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,3100 | −13 000 | −394 | 2 123 374 | ||||
2013-06-05 | 2013-06-03 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −1 900 | −57 | 2 136 374 | ||||
2013-06-04 | 2013-06-03 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −82 072 | −2 462 | 824 255 | ||||
2013-06-03 | 2013-05-31 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −9 935 | −298 | 906 327 | ||||
2013-06-03 | 2013-05-30 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −44 582 | −1 337 | 916 262 | ||||
2013-05-31 | 2013-05-31 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −3 033 | −91 | 2 138 274 | ||||
2013-05-31 | 2013-05-30 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −2 500 | −75 | 2 141 307 | ||||
2013-05-30 | 2013-05-29 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −20 411 | −612 | 960 844 | ||||
2013-05-30 | 2013-05-28 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 32,1400 | −5 300 | −170 | 981 255 | ||||
2013-05-30 | 2013-05-28 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 31,3800 | −74 980 | −2 353 | 986 555 | ||||
2013-05-30 | 2013-05-28 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,6200 | −114 837 | −3 516 | 1 061 535 | ||||
2013-05-24 | 2013-05-22 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −18 471 | −554 | 2 143 807 | ||||
2013-05-23 | 2013-05-22 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −7 340 | −220 | 1 176 372 | ||||
2013-05-22 | 2013-05-20 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −14 374 | −431 | 2 162 278 | ||||
2013-05-21 | 2013-05-20 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −13 550 | −406 | 1 183 712 | ||||
2013-05-17 | 2013-05-15 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 29,3000 | 853 | 25 | 853 | ||||
2013-05-08 | 2013-04-12 | 4 | EVNIN LUKE | PCRX | Common Stock Warrants (Right to Buy) | I | 2,69 | −37 192 | 0 | |||||
2013-05-08 | 2013-04-12 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 29,3000 | −3 416 | −100 | 1 314 255 | ||||
2013-05-08 | 2013-04-12 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 2,6900 | 37 192 | 100 | 1 317 671 | ||||
2013-04-29 | 2013-04-24 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0400 | −6 303 | −189 | 1 163 486 | ||||
2013-04-29 | 2013-04-23 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −108 115 | −3 243 | 1 169 789 | ||||
2013-04-25 | 2013-04-24 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0374 | −401 | −12 | 2 176 652 | ||||
2013-04-25 | 2013-04-23 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −15 646 | −469 | 2 177 053 | ||||
2013-04-18 | 2013-04-15 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −2 575 | −77 | 1 277 904 | ||||
2013-04-18 | 2013-04-12 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 30,0000 | −10 000 | −300 | 1 280 479 | ||||
2013-04-17 | 2013-04-15 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0032 | −6 400 | −192 | 2 192 699 | ||||
2013-04-16 | 2013-04-12 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | 10 000 | 19 042 | |||||
2013-04-16 | 2013-04-12 | 4 | PATOU GARY | PCRX | Common Stock | D | 30,0000 | −10 000 | −300 | 0 | ||||
2013-04-16 | 2013-04-12 | 4 | PATOU GARY | PCRX | Common Stock | D | 1,6100 | 10 000 | 16 | 10 000 | ||||
2013-04-15 | 2013-01-24 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 18,9300 | −500 000 | −9 465 | 882 562 | ||||
2013-04-15 | 2012-12-06 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | −98 596 | 0 | ||||||
2013-04-15 | 2013-03-11 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 27,8600 | −348 951 | −9 722 | 559 453 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 13,44 | −20 069 | 0 | |||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 13,44 | −843 | 0 | |||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 13,44 | −708 | 0 | |||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 13,44 | −20 220 | 0 | |||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 2,69 | −17 839 | 0 | |||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 2,69 | −750 | 0 | |||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 2,69 | −629 | 0 | |||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 2,69 | −17 973 | 0 | |||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −10 407 | −270 | 1 361 762 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −438 | −11 | 57 973 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −368 | −10 | 48 657 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −10 485 | −272 | 908 404 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 13,4400 | 20 069 | 270 | 1 372 169 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 13,4400 | 843 | 11 | 58 411 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 13,4400 | 708 | 10 | 49 025 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 13,4400 | 20 220 | 272 | 918 889 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −1 852 | −48 | 1 352 100 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −78 | −2 | 57 568 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −66 | −2 | 48 317 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −1 866 | −48 | 898 669 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 2,6900 | 17 839 | 48 | 1 353 952 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 2,6900 | 750 | 2 | 57 646 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 2,6900 | 629 | 2 | 48 383 | ||||
2013-04-15 | 2013-03-07 | 4/A | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 2,6900 | 17 973 | 48 | 900 535 | ||||
2013-04-15 | 2012-03-25 | 4 | MIDDLETON FRED A | PCRX | Common Stock | D | −5 000 | 62 966 | ||||||
2013-04-15 | 2013-04-12 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −34 294 | −1 029 | 2 199 099 | ||||
2013-04-15 | 2013-04-11 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 30,0000 | −600 | −18 | 2 233 393 | ||||
2013-04-03 | 2013-04-01 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 1,61 | 30 000 | 29 042 | |||||
2013-04-03 | 2013-04-01 | 4 | PATOU GARY | PCRX | Common Stock | D | 28,8200 | −11 300 | −326 | 0 | ||||
2013-04-03 | 2013-04-01 | 4 | PATOU GARY | PCRX | Common Stock | D | 27,7500 | −18 700 | −519 | 11 300 | ||||
2013-04-03 | 2013-04-01 | 4 | PATOU GARY | PCRX | Common Stock | D | 1,6100 | 30 000 | 48 | 30 000 | ||||
2013-04-01 | 2013-03-28 | 4 | Scibetta James S | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −10 000 | 62 989 | |||||
2013-04-01 | 2013-03-28 | 4 | Scibetta James S | PCRX | Common Stock | D | 28,4900 | −10 000 | −285 | 5 000 | ||||
2013-04-01 | 2013-03-28 | 4 | Scibetta James S | PCRX | Common Stock | D | 1,6100 | 10 000 | 16 | 15 000 | ||||
2013-04-01 | 2013-03-28 | 4 | STACK DAVID M | PCRX | Employee Stock Option (right to buy) | D | 1,61 | −15 000 | 240 695 | |||||
2013-04-01 | 2013-03-28 | 4 | STACK DAVID M | PCRX | Common Stock | D | 28,6600 | −15 000 | −430 | 2 573 | ||||
2013-04-01 | 2013-03-28 | 4 | STACK DAVID M | PCRX | Common Stock | D | 1,6100 | 15 000 | 24 | 17 573 | ||||
2013-04-01 | 2013-03-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Stock Option (right to buy) | D | 1,61 | −2 000 | 2 649 | |||||
2013-04-01 | 2013-03-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 28,4900 | −2 000 | −57 | 0 | ||||
2013-04-01 | 2013-03-28 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 1,6100 | 2 000 | 3 | 2 000 | ||||
2013-03-25 | 2013-03-25 | 4 | HBM Healthcare Investments (Cayman) Ltd. | PCRX | Common Stock | D | 28,2754 | −165 541 | −4 681 | 2 233 993 | ||||
2013-03-25 | 2013-03-22 | 4 | HBM Healthcare Investments (Cayman) Ltd. | PCRX | Common Stock | D | 27,5226 | −113 928 | −3 136 | 2 399 534 | ||||
2013-03-25 | 2013-03-21 | 4 | HBM Healthcare Investments (Cayman) Ltd. | PCRX | Common Stock | D | 27,5000 | −11 431 | −314 | 2 513 462 | ||||
2013-03-25 | 2013-03-18 | 4 | STACK DAVID M | PCRX | Common Stock | D | 573 | 2 573 | ||||||
2013-03-25 | 2013-03-25 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 28,2754 | −165 541 | −4 681 | 2 233 993 | ||||
2013-03-25 | 2013-03-22 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 27,5226 | −113 928 | −3 136 | 2 399 534 | ||||
2013-03-25 | 2013-03-21 | 4 | Wicki Andreas See footnote. | PCRX | Common Stock | I | 27,5000 | −11 431 | −314 | 2 513 462 | ||||
2013-03-21 | 2013-03-19 | 4 | HBM Healthcare Investments (Cayman) Ltd. | PCRX | Common Stock | D | 27,8572 | −9 100 | −254 | 2 524 893 | ||||
2013-03-21 | 2013-03-18 | 4 | HBM Healthcare Investments (Cayman) Ltd. | PCRX | Common Stock | D | 28,1937 | −400 000 | −11 277 | 2 533 993 | ||||
2013-03-21 | 2013-03-11 | 4 | HBM Healthcare Investments (Cayman) Ltd. | PCRX | Common Stock | D | 27,8600 | −500 000 | −13 930 | 2 933 993 | ||||
2013-03-21 | 2013-03-19 | 4 | Wicki Andreas | PCRX | Common Stock | I | 27,8572 | −9 100 | −254 | 2 524 893 | ||||
2013-03-21 | 2013-03-18 | 4 | Wicki Andreas | PCRX | Common Stock | I | 28,1937 | −400 000 | −11 277 | 2 533 993 | ||||
2013-03-21 | 2013-03-11 | 4 | Wicki Andreas | PCRX | Common Stock | I | 27,8600 | −500 000 | −13 930 | 2 933 993 | ||||
2013-03-20 | 2013-03-15 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 200 000 | 200 000 | ||||||
2013-03-20 | 2013-03-15 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | −1 000 000 | 361 762 | ||||||
2013-03-20 | 2013-03-19 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 26,9500 | −46 339 | −1 249 | 416 083 | ||||
2013-03-20 | 2013-03-19 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 27,6600 | −38 250 | −1 058 | 462 422 | ||||
2013-03-20 | 2013-03-18 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 28,1900 | −29 415 | −829 | 0 | ||||
2013-03-20 | 2013-03-18 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 28,1900 | −24 688 | −696 | 0 | ||||
2013-03-20 | 2013-03-18 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 28,1900 | −29 825 | −841 | 500 672 | ||||
2013-03-20 | 2013-03-18 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 29,2000 | −28 558 | −834 | 29 415 | ||||
2013-03-20 | 2013-03-18 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 29,2000 | −23 969 | −700 | 24 688 | ||||
2013-03-20 | 2013-03-18 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 29,2000 | −28 956 | −846 | 530 497 | ||||
2013-03-20 | 2013-03-15 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25 133 | 67 966 | ||||||
2013-03-20 | 2013-03-15 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | −200 000 | 0 | ||||||
2013-03-19 | 2013-03-18 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 28,4400 | −500 000 | −14 220 | 2 290 479 | ||||
2013-03-18 | 2013-03-14 | 4 | Riker Lauren Bullaro | PCRX | Employee Stock Option (right to buy) | D | 10,34 | −10 000 | 30 000 | |||||
2013-03-18 | 2013-03-14 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 30,0000 | −10 000 | −300 | 2 000 | ||||
2013-03-18 | 2013-03-14 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,3400 | 10 000 | 103 | 12 000 | ||||
2013-03-14 | 2013-03-12 | 4 | Pratt John | PCRX | Employee Stock Option (right to buy) | D | 8,73 | −9 375 | 20 625 | |||||
2013-03-14 | 2013-03-12 | 4 | Pratt John | PCRX | Common Stock | D | 28,4600 | −9 375 | −267 | 0 | ||||
2013-03-14 | 2013-03-12 | 4 | Pratt John | PCRX | Common Stock | D | 8,7300 | 9 375 | 82 | 9 375 | ||||
2013-03-13 | 2013-03-11 | 4 | EVNIN LUKE | PCRX | Common Stock | I | 27,8600 | −500 000 | −13 930 | 2 790 479 | ||||
2013-03-13 | 2013-03-11 | 4 | KAILIAN VAUGHN M | PCRX | Common Stock | I | 27,8600 | −500 000 | −13 930 | 2 790 479 | ||||
2013-03-13 | 2013-03-11 | 4 | MPM BioVentures IV QP LP | PCRX | Common Stock | I | 27,8600 | −500 000 | −13 930 | 2 790 479 | ||||
2013-03-11 | 2013-03-11 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 27,8600 | −348 951 | −9 722 | 559 453 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 13,44 | −20 069 | 0 | |||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 13,44 | −843 | 0 | |||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 13,44 | −708 | 0 | |||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 13,44 | −20 220 | 0 | |||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 2,69 | −17 839 | 0 | |||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 2,69 | −750 | 0 | |||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 2,69 | −629 | 0 | |||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock Warrants (right to buy) | D | 2,69 | −17 973 | 0 | |||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −10 407 | −270 | 1 361 762 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −438 | −11 | 57 973 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −368 | −10 | 48 657 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −10 485 | −272 | 908 404 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 13,4400 | 20 069 | 270 | 1 372 169 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 13,4400 | 843 | 11 | 58 411 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 13,4400 | 708 | 10 | 49 025 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 13,4400 | 20 220 | 272 | 918 889 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −1 852 | −48 | 1 352 100 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −78 | −2 | 57 568 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −66 | −2 | 48 317 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 25,9200 | −1 866 | −48 | 898 669 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 2,6900 | 17 839 | 48 | 1 353 952 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 2,6900 | 750 | 2 | 57 646 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 2,6900 | 629 | 2 | 48 383 | ||||
2013-03-11 | 2013-03-07 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 2,6900 | 17 973 | 48 | 900 535 | ||||
2013-01-25 | 2013-01-24 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 18,9300 | −500 000 | −9 465 | 882 562 | ||||
2013-01-25 | 2012-12-06 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | −98 596 | 0 | ||||||
2012-08-21 | 2012-08-17 | 4 | PACE GARY W | PCRX | Stock Option (right to buy) | D | 16,67 | 70 000 | 70 000 | |||||
2012-06-11 | 2012-06-05 | 4/A | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 10,81 | 40 000 | 40 000 | |||||
2012-06-11 | 2012-06-07 | 4 | PATOU GARY | PCRX | Stock Option (Right to Buy) | D | 11,68 | 60 000 | 60 000 | |||||
2012-06-07 | 2012-06-05 | 4 | Brege Laura | PCRX | Common Stock | D | 10,81 | 7 000 | 7 000 | |||||
2012-06-07 | 2012-06-05 | 4 | STACK DAVID M | PCRX | Common Stock | D | 10,81 | 350 000 | 350 000 | |||||
2012-06-07 | 2012-06-05 | 4 | HASTINGS PAUL J | PCRX | Common Stock | D | 10,81 | 7 000 | 7 000 | |||||
2012-06-07 | 2012-06-05 | 4 | MIDDLETON FRED A | PCRX | Common Stock | D | 10,81 | 7 000 | 7 000 | |||||
2012-06-07 | 2012-06-05 | 4 | LONGENECKER JOHN P PHD | PCRX | Common Stock | D | 10,81 | 7 000 | 7 000 | |||||
2012-06-07 | 2012-06-05 | 4 | PACE GARY W | PCRX | Common Stock | D | 10,81 | 7 000 | 7 000 | |||||
2012-06-07 | 2012-06-05 | 4 | PATOU GARY | PCRX | Director Stock Option (Right to Buy) | D | 10,81 | 40 000 | 40 000 | |||||
2012-06-07 | 2012-06-05 | 4 | Scibetta James S | PCRX | Common Stock | D | 10,81 | 150 000 | 150 000 | |||||
2012-06-07 | 2012-06-05 | 4 | Pratt John | PCRX | Common Stock | D | 10,81 | 150 000 | 150 000 | |||||
2012-06-07 | 2012-06-05 | 4 | Markvicka Taunia | PCRX | Common Stock | D | 10,81 | 150 000 | 150 000 | |||||
2012-06-07 | 2012-06-05 | 4 | Riker Lauren Bullaro | PCRX | Common Stock | D | 10,81 | 30 000 | 30 000 | |||||
2012-06-06 | 2012-06-05 | 4 | EVNIN LUKE | PCRX | Director Stock Option (Right to Buy) | D | 10,81 | 7 000 | 7 000 | |||||
2012-04-17 | 2012-04-17 | 4 | PACE GARY W | PCRX | Common Stock | D | 9,7500 | 10 000 | 98 | 17 692 | ||||
2012-04-05 | 2012-04-03 | 4 | PACE GARY W | PCRX | Common Stock | D | 11,02 | 20 000 | 30 000 | |||||
2012-04-05 | 2012-04-03 | 4 | PACE GARY W | PCRX | Common Stock | D | 11,02 | 10 000 | 10 000 | |||||
2012-03-29 | 3 | Riker Lauren Bullaro | PCRX | Common Stock | D | 2 000 | ||||||||
2012-03-13 | 2012-03-12 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,0318 | −700 | −8 | 2 446 000 | ||||
2012-03-13 | 2012-03-12 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,0318 | −62 400 | −688 | 2 446 700 | ||||
2012-03-13 | 2012-03-09 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,2456 | −300 | −3 | 2 509 100 | ||||
2012-03-13 | 2012-03-09 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,2456 | −36 700 | −413 | 2 509 400 | ||||
2012-02-29 | 2012-02-29 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 10,8614 | −3 000 | −33 | 2 546 100 | ||||
2012-02-29 | 2012-02-28 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,1204 | −100 | −1 | 2 549 100 | ||||
2012-02-29 | 2012-02-28 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,1204 | −10 000 | −111 | 2 549 200 | ||||
2012-02-29 | 2012-02-27 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,0472 | −300 | −3 | 2 559 200 | ||||
2012-02-29 | 2012-02-27 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,0472 | −28 700 | −317 | 2 559 500 | ||||
2012-02-10 | 2011-08-10 | 5 | STACK DAVID M | PCRX | Common Stock | D | −3 000 | 20 600 | ||||||
2012-02-03 | 2012-02-03 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 10,7904 | −500 | −5 | 2 588 200 | ||||
2012-02-03 | 2012-02-03 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 10,7904 | −49 500 | −534 | 2 588 700 | ||||
2012-02-03 | 2012-02-02 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 10,8548 | −200 | −2 | 2 638 200 | ||||
2012-02-03 | 2012-02-02 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 10,8548 | −23 100 | −251 | 2 638 400 | ||||
2012-02-03 | 2012-02-01 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,0058 | −700 | −8 | 2 661 500 | ||||
2012-02-03 | 2012-02-01 | 4 | ORBIMED ADVISORS LLC See footnotes | PCRX | Common Stock | I | 11,0058 | −69 300 | −763 | 2 662 200 | ||||
2012-01-05 | 2012-01-03 | 4 | Pratt John | PCRX | Employee Stock Option (right to buy) | D | 8,73 | 30 000 | 30 000 | |||||
2011-06-06 | 2011-06-02 | 4 | HASTINGS PAUL J | PCRX | Stock option (right to buy) | D | 13,98 | 15 000 | 15 000 | |||||
2011-06-06 | 2011-06-02 | 4 | MIDDLETON FRED A | PCRX | Stock option (right to buy) | D | 13,98 | 15 692 | 15 692 | |||||
2011-06-06 | 3 | HASTINGS PAUL J | PCRX | Common Stock | D | 0 | ||||||||
2011-06-06 | 3 | Brege Laura | PCRX | Common Stock | D | 0 | ||||||||
2011-06-06 | 2011-06-02 | 4 | Brege Laura | PCRX | Stock option (right to buy) | D | 13,98 | 15 000 | 15 000 | |||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Convertible Promissory Notes | D | −128 479 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Convertible Promissory Notes | D | −5 400 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Convertible Promissory Notes | D | −4 533 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Convertible Promissory Notes | D | −129 445 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Convertible Promissory Notes | D | −341 788 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Convertible Promissory Notes | D | −14 366 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Convertible Promissory Notes | D | −12 058 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Convertible Promissory Notes | D | −344 355 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Series A Convertible Preferred Stock | D | −681 715 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Series A Convertible Preferred Stock | D | −29 634 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Series A Convertible Preferred Stock | D | −24 871 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Series A Convertible Preferred Stock | D | −14 877 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Series A Convertible Preferred Stock | D | −736 583 | 0 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 7,0000 | 46 379 | 325 | 46 379 | ||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 128 479 | 128 479 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 5 400 | 5 400 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 4 533 | 4 533 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 129 445 | 129 445 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 341 788 | 341 788 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 14 366 | 14 366 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 12 058 | 12 058 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 344 355 | 344 355 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 681 715 | 681 715 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 29 634 | 29 634 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 24 871 | 24 871 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 14 877 | 14 877 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 736 583 | 736 583 | ||||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 7,0000 | 184 131 | 1 289 | 184 131 | ||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 7,0000 | 5 119 | 36 | 5 119 | ||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 7,0000 | 4 297 | 30 | 4 297 | ||||
2011-02-10 | 2011-02-08 | 4 | Sanderling Venture Partners VI LP | PCRX | Common Stock | D | 7,0000 | 27 931 | 196 | 27 931 | ||||
2011-02-02 | 3 | STACK DAVID M | PCRX | Common Stock | I | 18 600 | ||||||||
2011-02-02 | 3 | Sanderling Venture Partners VI Co Investment Fund LP | PCRX | Common Stock | D | 125 800 | ||||||||
2011-02-02 | 3 | Sanderling Venture Partners VI Co Investment Fund LP | PCRX | Common Stock | D | 55 788 | ||||||||
2011-02-02 | 3 | Sanderling Venture Partners VI Co Investment Fund LP | PCRX | Common Stock | D | 1 995 | ||||||||
2011-02-02 | 3 | Sanderling Venture Partners VI Co Investment Fund LP | PCRX | Common Stock | D | 2 377 | ||||||||
2011-02-02 | 3 | Wicki Andreas | PCRX | Common Stock | I | 92 980 |